How many Cabozantinib clinical trials are there?

251 Cabozantinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 54 are actively recruiting participants. 88 are marked completed.

Are Cabozantinib clinical trials recruiting in 2026?

Yes — 54 Cabozantinib trials are actively recruiting in 2026, with 1549 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Cabozantinib being studied for?

Cabozantinib is being studied for Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Hepatocellular Carcinoma, Stage IV Renal Cell Cancer AJCC v8, Clear Cell Renal Cell Carcinoma and 748 more. The trials are grouped by indication on this page.

What phase is Cabozantinib in?

Cabozantinib clinical trials span 5 Phase 4, 26 Phase 3, 147 Phase 2, 41 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Cabozantinib clinical trials?

The lead sponsor across the most Cabozantinib trials is National Cancer Institute (NCI), with 115 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Cabozantinib Clinical Trials (2026): 251 Studies for Renal Cell Carcinoma & Metastatic Renal Cell Carcinoma

Creator: Hipa.ai Research
Published: 2026-05-14T21:41:02.033Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: July 17, 2026.

251 Cabozantinib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 164 indications (including Renal Cell Carcinoma & Metastatic Renal Cell Carcinoma) and 37,902 total planned enrollment. 26 Phase 3 Cabozantinib trials and 147 Phase 2, 5 Phase 4 are listed. 61 Cabozantinib clinical trials are actively recruiting at 1,549 U.S. sites across 51 states. Most recent activity: NCT04760288 (Apr 2035).

Where to Participate: All Cabozantinib Trial Sites in the U.S. (1,549 sites across 51 states)

Every actively recruiting Cabozantinibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AL	Children's Hospital of Alabama	Birmingham35233	NCT05691478	Map
AL	Children's Hospital of Alabama/UAB	Birmingham35233	NCT05135975	Map
AL	Research Site	Birmingham35294	NCT05536141	Map
AL	University of Alabama at Birmingham (Children's of Alabama)	Birmingham35233	NCT07194044	Map
AK	Alaska Breast Care and Surgery LLC	Anchorage99508	NCT06475989	Map
AK	Alaska Oncology and Hematology ( Site 0133)	Anchorage99508	NCT07227402	Map
AK	Alaska Oncology and Hematology LLC	Anchorage99508	NCT06475989	Map
AK	Alaska Women's Cancer Care	Anchorage99508	NCT06475989	Map
AK	Anchorage Associates in Radiation Medicine	Anchorage98508	NCT06475989	Map
AK	Katmai Oncology Group	Anchorage99508	NCT06475989	Map
AK	Providence Alaska Medical Center	Anchorage99508	NCT06475989	Map
AZ	Research Site	Gilbert85234	NCT07011719	Map
AZ	Research Site	Goodyear85338	NCT07011719	Map
AZ	Kingman Regional Medical Center	Kingman86401	NCT05327686	Map
AZ	Banner Children's at Desert	Mesa85202	NCT05691478	Map
AZ	Mayo Clinic Comprehensive Cancer Center	Phoenix85054	NCT06026410	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT05773274	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT05136196	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT05327686	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT05691478	Map
AZ	Mayo Clinic Hospital in Arizona	Phoenix85054	NCT03866382	Map
AZ	Phoenix Children's Hospital	Phoenix85016	NCT07194044	Map
AZ	Phoenix Childrens Hospital	Phoenix85016	NCT05691478	Map
AZ	Research Site	Phoenix85054	NCT07011719	Map
AZ	Mayo Clinic in Arizona	Scottsdale85259	NCT05168163	Map
AZ	Mayo Clinic in Arizona	Scottsdale85259	NCT03866382	Map
AZ	Banner University Medical Center - Tucson	Tucson85719	NCT05773274	Map
AZ	Banner University Medical Center - Tucson	Tucson85719	NCT05691478	Map
AZ	University of Arizona	Tucson85724	NCT06026410	Map
AZ	University of Arizona Cancer Center-North Campus	Tucson85719	NCT05773274	Map
AR	Highlands Oncology Group - Fayetteville	Fayetteville72703	NCT07383441	Map
AR	Mercy Hospital Fort Smith	Fort Smith72903	NCT06475989	Map
AR	NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro	Jonesboro72401	NCT07383441	Map
AR	Arkansas Children's Hospital	Little Rock72202-3591	NCT05691478	Map
AR	CARTI Cancer Center	Little Rock72205	NCT06475989	Map
AR	University of Arkansas for Medical Sciences	Little Rock72205	NCT05136196	Map
AR	University of Arkansas for Medical Sciences	Little Rock72205	NCT05327686	Map
AR	Highlands Oncology Group - Rogers	Rogers72758	NCT07383441	Map
AR	Highlands Oncology Group	Springdale72762	NCT07383441	Map
CA	PCR Oncology	Arroyo Grande93420	NCT05327686	Map
CA	Tower Cancer Research Foundation	Beverly Hills90211	NCT05136196	Map
CA	Tower Cancer Research Foundation	Beverly Hills90211	NCT05327686	Map
CA	Providence Saint Joseph Medical Center/Disney Family Cancer Center	Burbank91505	NCT06475989	Map
CA	Mills-Peninsula Medical Center	Burlingame94010	NCT05327686	Map
CA	Kaiser Permanente Downey Medical Center	Downey90242	NCT05691478	Map
CA	City of Hope	Duarte91010	NCT05797805	Map
CA	City of Hope Comprehensive Cancer Center	Duarte91010	NCT05691478	Map
CA	City of Hope National Medical Center	Duarte91010	NCT05361720	Map
CA	Research Site	Duarte91010	NCT07011719	Map
CA	UC San Diego Health System - Encinitas	Encinitas92024	NCT05327686	Map
CA	Providence Medical Foundation ( Site 0141)	Fullerton92835	NCT07227402	Map
CA	UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care	Irvine92612	NCT06475989	Map
CA	UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care	Irvine92612	NCT05136196	Map
CA	UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care	Irvine92612	NCT05327686	Map
CA	UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care	Irvine92612	NCT06811116	Map
CA	Research Site	La Jolla92103	NCT07011719	Map
CA	UC San Diego Moores Cancer Center	La Jolla92093	NCT05327686	Map
CA	UC San Diego Moores Cancer Center	La Jolla92093	NCT06900595	Map
CA	Loma Linda University Medical Center	Loma Linda92354	NCT05691478	Map
CA	Miller Children's and Women's Hospital Long Beach	Long Beach90806	NCT05691478	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT05136196	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT06026410	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT05327686	Map
CA	Cedars-Sinai Medical Center	Los Angeles90048	NCT05691478	Map
CA	Children's Hospital Los Angeles	Los Angeles90027	NCT05691478	Map
CA	Keck Medicine of USC Koreatown	Los Angeles90020	NCT03866382	Map
CA	Los Angeles General Medical Center	Los Angeles90033	NCT05327686	Map
CA	Los Angeles General Medical Center	Los Angeles90033	NCT03866382	Map
CA	Research Site	Los Angeles90095	NCT07011719	Map
CA	The Angeles Clinic and Research Institute - West Los Angeles Office	Los Angeles90025	NCT05136196	Map
CA	UCLA Department of Medicine	Los Angeles90095	NCT06026410	Map
CA	University of Southern California	Los Angeles90033	NCT06026410	Map
CA	USC / Norris Comprehensive Cancer Center	Los Angeles90033	NCT05327686	Map
CA	USC / Norris Comprehensive Cancer Center	Los Angeles90033	NCT03866382	Map
CA	Valley Children's Hospital	Madera93636	NCT05691478	Map
CA	Valley Children's Hospital	Madera93636	NCT06900595	Map
CA	Memorial Medical Center	Modesto95355	NCT05327686	Map
CA	Providence Queen of The Valley	Napa94558	NCT06475989	Map
CA	USC Norris Oncology/Hematology-Newport Beach	Newport Beach92663	NCT03866382	Map
CA	Kaiser Permanente-Oakland	Oakland94611	NCT05691478	Map
CA	UCSF Benioff Children's Hospital Oakland	Oakland94609	NCT05691478	Map
CA	Chao Family Comprehensive Cancer Center	Orange92868	NCT05361720	Map
CA	Chao Family Comprehensive Cancer Center, University of California, Irvine	Orange92868	NCT04472767	Map
CA	Children's Hospital of Orange County	Orange92868	NCT05691478	Map
CA	UC Irvine Health/Chao Family Comprehensive Cancer Center	Orange92868	NCT06475989	Map
CA	UC Irvine Health/Chao Family Comprehensive Cancer Center	Orange92868	NCT05136196	Map
CA	UC Irvine Health/Chao Family Comprehensive Cancer Center	Orange92868	NCT05327686	Map
CA	UC Irvine Health/Chao Family Comprehensive Cancer Center	Orange92868	NCT06811116	Map
CA	Lucile Packard Children's Hospital Stanford University	Palo Alto94304	NCT05691478	Map
CA	Stanford Cancer Institute Palo Alto	Palo Alto94304	NCT06475989	Map
CA	Sutter Cancer Centers Radiation Oncology Services-Roseville	Roseville95661	NCT05327686	Map
CA	Sutter Roseville Medical Center	Roseville95661	NCT05327686	Map
CA	Research Site	Sacramento95817	NCT07011719	Map
CA	Sutter Medical Center Sacramento	Sacramento95816	NCT05327686	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT03816345	Map
CA	University of California Davis Comprehensive Cancer Center	Sacramento95817	NCT05691478	Map
CA	Rady Children's Hospital - San Diego	San Diego92123	NCT05691478	Map
CA	Research Site	San Diego92103	NCT07011719	Map
CA	Research Site	San Diego92093	NCT05536141	Map
CA	UC San Diego Medical Center - Hillcrest	San Diego92103	NCT05327686	Map
CA	UCSF Medical Center-Mission Bay	San Francisco94158	NCT05327686	Map
CA	UCSF Medical Center-Mission Bay	San Francisco94158	NCT05691478	Map
CA	University of California San Francisco	San Francisco94143	NCT06156410	Map
CA	Mills Health Center	San Mateo94401	NCT05327686	Map
CA	Ridley-Tree Cancer Center	Santa Barbara93105	NCT05327686	Map
CA	Research Site	Santa Monica90404	NCT05536141	Map
CA	Providence Medical Foundation - Santa Rosa	Santa Rosa95403	NCT06475989	Map
CA	Providence Santa Rosa Memorial Hospital	Santa Rosa95405	NCT06475989	Map
CA	Sutter Pacific Medical Foundation	Santa Rosa95403	NCT05327686	Map
CO	Children's Hospital Colorado	Aurora80045	NCT05691478	Map
CO	Children's Hospital Colorado	Aurora80045	NCT06156410	Map
CO	Children's Hospital of Colorado	Aurora80045	NCT05135975	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT06475989	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT05773274	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT05327686	Map
CO	UCHealth University of Colorado Hospital	Aurora80045	NCT06900595	Map
CO	Memorial Hospital North	Colorado Springs80920	NCT05136196	Map
CO	UCHealth Memorial Hospital Central	Colorado Springs80909	NCT05136196	Map
CO	Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center	Denver80218	NCT05691478	Map
CO	Sarah Cannon Research Institute at HealthONE	Denver80218	NCT06026410	Map
CO	UCHealth - Cherry Creek	Denver80206	NCT05327686	Map
CO	Cancer Care and Hematology-Fort Collins	Fort Collins80528	NCT05136196	Map
CO	Cancer Care and Hematology-Fort Collins	Fort Collins80528	NCT05327686	Map
CO	Poudre Valley Hospital	Fort Collins80524	NCT05136196	Map
CO	Poudre Valley Hospital	Fort Collins80524	NCT05327686	Map
CO	UCHealth Greeley Hospital	Greeley80631	NCT05136196	Map
CO	UCHealth Greeley Hospital	Greeley80631	NCT05327686	Map
CO	UCHealth Highlands Ranch Hospital	Highlands Ranch80129	NCT06475989	Map
CO	UCHealth Highlands Ranch Hospital	Highlands Ranch80129	NCT05327686	Map
CO	UCHealth Lone Tree Health Center	Lone Tree80124	NCT05327686	Map
CO	Medical Center of the Rockies	Loveland80538	NCT05136196	Map
CO	Medical Center of the Rockies	Loveland80538	NCT05327686	Map
CT	Smilow Cancer Hospital-Derby Care Center	Derby06418	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center-Fairfield	Fairfield06824	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center at Glastonbury	Glastonbury06033	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center at Greenwich	Greenwich06830	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center - Guilford	Guilford06437	NCT06475989	Map
CT	Connecticut Children's Medical Center	Hartford06106	NCT05691478	Map
CT	Smilow Cancer Hospital Care Center at Saint Francis	Hartford06105	NCT06475989	Map
CT	Research Site	New Haven06519	NCT07011719	Map
CT	Smilow Cancer Center/Yale-New Haven Hospital	New Haven06510	NCT06475989	Map
CT	Smilow Cancer Center/Yale-New Haven Hospital	New Haven06510	NCT03816345	Map
CT	Yale University	New Haven06520	NCT06475989	Map
CT	Yale University	New Haven06520	NCT03816345	Map
CT	Yale University	New Haven06520	NCT05691478	Map
CT	Yale-New Haven Hospital North Haven Medical Center	North Haven06473	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center at Long Ridge	Stamford06902	NCT06475989	Map
CT	Smilow Cancer Hospital-Torrington Care Center	Torrington06790	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center-Trumbull	Trumbull06611	NCT06475989	Map
CT	Smilow Cancer Hospital-Waterbury Care Center	Waterbury06708	NCT06475989	Map
CT	Smilow Cancer Hospital Care Center - Waterford	Waterford06385	NCT06475989	Map
DE	Beebe Medical Center	Lewes19958	NCT05327686	Map
DE	Beebe South Coastal Health Campus	Millville19967	NCT05327686	Map
DE	Christiana Care Health System-Christiana Hospital	Newark19718	NCT05327686	Map
DE	Helen F Graham Cancer Center	Newark19713	NCT05136196	Map
DE	Helen F Graham Cancer Center	Newark19713	NCT05327686	Map
DE	Medical Oncology Hematology Consultants PA	Newark19713	NCT05136196	Map
DE	Medical Oncology Hematology Consultants PA	Newark19713	NCT05327686	Map
DE	Beebe Health Campus	Rehoboth Beach19971	NCT05327686	Map
DE	Alfred I duPont Hospital for Children	Wilmington19803	NCT05691478	Map
DE	Christiana Care Health System-Wilmington Hospital	Wilmington19801	NCT05327686	Map
DC	Children's National Medical Center	Washington D.C.20010	NCT05135975	Map
DC	Children's National Medical Center	Washington D.C.20010	NCT05691478	Map
DC	MedStar Georgetown University Hospital	Washington D.C.20007	NCT03816345	Map
DC	MedStar Georgetown University Hospital	Washington D.C.20007	NCT05691478	Map
DC	MedStar Georgetown University Hospital	Washington D.C.20007	NCT03866382	Map
DC	Research Site	Washington D.C.20057	NCT07011719	Map
DC	Sibley Memorial Hospital	Washington D.C.20016	NCT07293351	Map
FL	Mount Sinai Comprehensive Cancer Center at Aventura	Aventura33180	NCT05327686	Map
FL	UM Sylvester Comprehensive Cancer Center at Aventura	Aventura33180	NCT05773274	Map
FL	AdventHealth Celebration	Celebration34747	NCT06026410	Map
FL	UM Sylvester Comprehensive Cancer Center at Coral Gables	Coral Gables33146	NCT05773274	Map
FL	UM Sylvester Comprehensive Cancer Center at Deerfield Beach	Deerfield Beach33442	NCT05773274	Map
FL	Holy Cross Hospital	Fort Lauderdale33308	NCT06475989	Map
FL	Holy Cross Hospital	Fort Lauderdale33308	NCT03866382	Map
FL	Golisano Children's Hospital of Southwest Florida	Fort Myers33908	NCT05691478	Map
FL	UF Health Cancer Institute - Gainesville	Gainesville32610	NCT05691478	Map
FL	University of Florida	Gainesville32610	NCT07194044	Map
FL	Memorial Regional Hospital/Joe DiMaggio Children's Hospital	Hollywood33021	NCT05327686	Map
FL	Memorial Regional Hospital/Joe DiMaggio Children's Hospital	Hollywood33021	NCT05691478	Map
FL	Mayo Clinic Comprehensive Cancer Center	Jacksonville32224	NCT06026410	Map
FL	Mayo Clinic in Florida	Jacksonville32224-9980	NCT06475989	Map
FL	Mayo Clinic in Florida	Jacksonville32224-9980	NCT05773274	Map
FL	Mayo Clinic in Florida	Jacksonville32224-9980	NCT05136196	Map
FL	Mayo Clinic in Florida	Jacksonville32224-9980	NCT05327686	Map
FL	Nemours Children's Clinic-Jacksonville	Jacksonville32207	NCT05691478	Map
FL	Research Site	Jacksonville32224	NCT07011719	Map
FL	Miami Cancer Institute	Miami33176	NCT05327686	Map
FL	Miami Cancer Institute	Miami33176	NCT05691478	Map
FL	Miami Cancer Institute at Baptist Health, Inc.	Miami33176	NCT05425004	Map
FL	Nicklaus Children's Hospital	Miami33155	NCT05691478	Map
FL	Research Site	Miami33136	NCT07011719	Map
FL	Research Site	Miami33136	NCT05536141	Map
FL	Sylvester Comprehensive Cancer Center	Miami33136	NCT05797805	Map
FL	UM Sylvester Comprehensive Cancer Center at Kendall	Miami33176	NCT05773274	Map
FL	University of Miami	Miami33136	NCT07194044	Map
FL	University of Miami Miller School of Medicine-Sylvester Cancer Center	Miami33136	NCT05773274	Map
FL	University of Miami Miller School of Medicine-Sylvester Cancer Center	Miami33136	NCT05691478	Map
FL	Mount Sinai Medical Center	Miami Beach33140	NCT05327686	Map
FL	University of Miami Sylvester Comprehensive Cancer Center at Sole Mia	North Miami33181	NCT05773274	Map
FL	AdventHealth Orlando	Orlando32803	NCT05691478	Map
FL	Arnold Palmer Hospital for Children	Orlando32806	NCT05691478	Map
FL	Nemours Children's Hospital	Orlando32827	NCT05691478	Map
FL	Orlando Health Cancer Institute	Orlando32806	NCT03866382	Map
FL	Research Site	Orlando32804	NCT07011719	Map
FL	Memorial Hospital West	Pembroke Pines33028	NCT05327686	Map
FL	Nemours Children's Clinic - Pensacola	Pensacola32504	NCT05691478	Map
FL	UM Sylvester Comprehensive Cancer Center at Plantation	Plantation33324	NCT05773274	Map
FL	Florida Cancer Specialists	Sarasota34232	NCT06026410	Map
FL	Johns Hopkins All Children's Hospital	St. Petersburg33701	NCT05691478	Map
FL	Moffitt Cancer Center	Tampa33612	NCT07194044	Map
FL	Saint Joseph's Hospital/Children's Hospital-Tampa	Tampa33607	NCT05691478	Map
GA	Children's Healthcare of Atlanta - Arthur M Blank Hospital	Atlanta30329	NCT05691478	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT06475989	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT06006013	Map
GA	Emory University Hospital Midtown	Atlanta30308	NCT03866382	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT06006013	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT04878029	Map
GA	Emory University Hospital/Winship Cancer Institute	Atlanta30322	NCT03866382	Map
GA	Research Site	Atlanta30318	NCT07011719	Map
GA	Research Site	Atlanta30322	NCT07011719	Map
GA	Research Site	Atlanta30322-1013	NCT05536141	Map
GA	Augusta University Medical Center	Augusta30912	NCT05691478	Map
GA	Research Site	Newnan30265	NCT07011719	Map
GA	Memorial Health University Medical Center	Savannah31404	NCT05691478	Map
HI	Kapiolani Medical Center for Women and Children	Honolulu96826	NCT05691478	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT06475989	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT05136196	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT05327686	Map
ID	Saint Alphonsus Cancer Care Center-Boise	Boise83706	NCT03866382	Map
ID	Saint Luke's Cancer Institute - Boise	Boise83712	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Boise	Boise83712	NCT05136196	Map
ID	Saint Luke's Cancer Institute - Boise	Boise83712	NCT05691478	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT06475989	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT05136196	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT05327686	Map
ID	Saint Alphonsus Cancer Care Center-Caldwell	Caldwell83605	NCT03866382	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT06475989	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT05136196	Map
ID	Kootenai Health - Coeur d'Alene	Coeur d'Alene83814	NCT03866382	Map
ID	Saint Luke's Cancer Institute - Fruitland	Fruitland83619	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Fruitland	Fruitland83619	NCT05136196	Map
ID	Idaho Urologic Institute-Meridian	Meridian83642	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Meridian	Meridian83642	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Meridian	Meridian83642	NCT05136196	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT06475989	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT05136196	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT05327686	Map
ID	Saint Alphonsus Cancer Care Center-Nampa	Nampa83687	NCT03866382	Map
ID	Saint Luke's Cancer Institute - Nampa	Nampa83687	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Nampa	Nampa83687	NCT05136196	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT06475989	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT05136196	Map
ID	Kootenai Clinic Cancer Services - Post Falls	Post Falls83854	NCT03866382	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT06475989	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT05136196	Map
ID	Kootenai Clinic Cancer Services - Sandpoint	Sandpoint83864	NCT03866382	Map
ID	Saint Luke's Cancer Institute - Twin Falls	Twin Falls83301	NCT06475989	Map
ID	Saint Luke's Cancer Institute - Twin Falls	Twin Falls83301	NCT05136196	Map
IL	OSF Saint Anthony's Health Center	Alton62002	NCT06475989	Map
IL	Advocate Outpatient Center - Aurora	Aurora60506	NCT06475989	Map
IL	Rush-Copley Medical Center	Aurora60504	NCT05136196	Map
IL	Advocate Good Shepherd Hospital	Barrington60010	NCT06475989	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT05136196	Map
IL	Illinois CancerCare-Bloomington	Bloomington61704	NCT07383441	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT05136196	Map
IL	Illinois CancerCare-Canton	Canton61520	NCT07383441	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT05136196	Map
IL	Illinois CancerCare-Carthage	Carthage62321	NCT07383441	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT05136196	Map
IL	Centralia Oncology Clinic	Centralia62801	NCT05327686	Map
IL	Advocate Illinois Masonic Medical Center	Chicago60657	NCT06475989	Map
IL	Lurie Children's Hospital-Chicago	Chicago60611	NCT05691478	Map
IL	Lurie Children's Hospital-Chicago	Chicago60611	NCT06900595	Map
IL	Northwestern University	Chicago60611	NCT06475989	Map
IL	Northwestern University	Chicago60611	NCT05773274	Map
IL	Northwestern University	Chicago60611	NCT05136196	Map
IL	Northwestern University	Chicago60611	NCT05327686	Map
IL	Northwestern University	Chicago60611	NCT05691478	Map
IL	Northwestern University	Chicago60611	NCT06900595	Map
IL	Rush MD Anderson Cancer Center	Chicago60612	NCT03866382	Map
IL	Ryan Nguyen	Chicago60612	NCT05613413	Map
IL	University of Chicago	Chicago60637	NCT05797805	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT06475989	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT05773274	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT05327686	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT05691478	Map
IL	University of Chicago Comprehensive Cancer Center	Chicago60637	NCT03866382	Map
IL	University of Illinois	Chicago60612	NCT06475989	Map
IL	University of Illinois	Chicago60612	NCT05136196	Map
IL	University of Illinois	Chicago60612	NCT05691478	Map
IL	AMG Crystal Lake - Oncology	Crystal Lake60014	NCT06475989	Map
IL	Carle at The Riverfront	Danville61832	NCT05136196	Map
IL	Carle at The Riverfront	Danville61832	NCT05327686	Map
IL	Carle at The Riverfront	Danville61832	NCT06900595	Map
IL	Carle at The Riverfront	Danville61832	NCT03866382	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT05136196	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT05327686	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT03866382	Map
IL	Cancer Care Specialists of Illinois - Decatur	Decatur62526	NCT07383441	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT05136196	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT05327686	Map
IL	Decatur Memorial Hospital	Decatur62526	NCT07383441	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT06475989	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05773274	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05136196	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT05327686	Map
IL	Northwestern Medicine Cancer Center Kishwaukee	DeKalb60115	NCT06900595	Map
IL	Illinois CancerCare-Dixon	Dixon61021	NCT05136196	Map
IL	Advocate Good Samaritan Hospital	Downers Grove60515	NCT06475989	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT05136196	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT05327686	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT06900595	Map
IL	Carle Physician Group-Effingham	Effingham62401	NCT03866382	Map
IL	Crossroads Cancer Center	Effingham62401	NCT05136196	Map
IL	Crossroads Cancer Center	Effingham62401	NCT05327686	Map
IL	Crossroads Cancer Center	Effingham62401	NCT03866382	Map
IL	Advocate Sherman Hospital	Elgin60123	NCT06475989	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT05136196	Map
IL	Illinois CancerCare-Eureka	Eureka61530	NCT07383441	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT05136196	Map
IL	Illinois CancerCare-Galesburg	Galesburg61401	NCT07383441	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT06475989	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05773274	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05136196	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT05327686	Map
IL	Northwestern Medicine Cancer Center Delnor	Geneva60134	NCT06900595	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT06475989	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT05327686	Map
IL	Northwestern Medicine Glenview Outpatient Center	Glenview60026	NCT06900595	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT06475989	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT05327686	Map
IL	Northwestern Medicine Grayslake Outpatient Center	Grayslake60030	NCT06900595	Map
IL	Ingalls Memorial Hospital	Harvey60426	NCT05327686	Map
IL	Advocate South Suburban Hospital	Hazel Crest60429	NCT06475989	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT05136196	Map
IL	Illinois CancerCare-Kewanee Clinic	Kewanee61443	NCT07383441	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT06475989	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT05136196	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT05327686	Map
IL	Northwestern Medicine Lake Forest Hospital	Lake Forest60045	NCT06900595	Map
IL	AMG Libertyville - Oncology	Libertyville60048	NCT06475989	Map
IL	Condell Memorial Hospital	Libertyville60048	NCT06475989	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT05136196	Map
IL	Illinois CancerCare-Macomb	Macomb61455	NCT07383441	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT05136196	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT05327686	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT06900595	Map
IL	Carle Physician Group-Mattoon/Charleston	Mattoon61938	NCT03866382	Map
IL	Loyola University Medical Center	Maywood60153	NCT05136196	Map
IL	Loyola University Medical Center	Maywood60153	NCT03866382	Map
IL	SSM Health Good Samaritan	Mount Vernon62864	NCT06475989	Map
IL	UC Comprehensive Cancer Center at Silver Cross	New Lenox60451	NCT06475989	Map
IL	UC Comprehensive Cancer Center at Silver Cross	New Lenox60451	NCT05773274	Map
IL	UC Comprehensive Cancer Center at Silver Cross	New Lenox60451	NCT05327686	Map
IL	UC Comprehensive Cancer Center at Silver Cross	New Lenox60451	NCT03866382	Map
IL	Carle BroMenn Medical Center	Normal61761	NCT06900595	Map
IL	Carle Cancer Institute Normal	Normal61761	NCT06900595	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT05136196	Map
IL	Cancer Care Center of O'Fallon	O'Fallon62269	NCT05327686	Map
IL	HSHS Saint Elizabeth's Hospital	O'Fallon62269	NCT05327686	Map
IL	Northwestern Medicine Oak Brook	Oak Brook60523	NCT05327686	Map
IL	Northwestern Medicine Oak Brook	Oak Brook60523	NCT06900595	Map
IL	Advocate Christ Medical Center	Oak Lawn60453-2699	NCT06475989	Map
IL	Advocate Outpatient Center - Oak Lawn	Oak Lawn60453	NCT06475989	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT06475989	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT05136196	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT05327686	Map
IL	Northwestern Medicine Orland Park	Orland Park60462	NCT06900595	Map
IL	University of Chicago Medicine-Orland Park	Orland Park60462	NCT06475989	Map
IL	University of Chicago Medicine-Orland Park	Orland Park60462	NCT05773274	Map
IL	University of Chicago Medicine-Orland Park	Orland Park60462	NCT05327686	Map
IL	University of Chicago Medicine-Orland Park	Orland Park60462	NCT03866382	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT05136196	Map
IL	Illinois CancerCare-Ottawa Clinic	Ottawa61350	NCT07383441	Map
IL	Advocate High Tech Medical Park	Palos Heights60463	NCT06475989	Map
IL	Advocate Lutheran General Hospital	Park Ridge60068	NCT06475989	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT05136196	Map
IL	Illinois CancerCare-Pekin	Pekin61554	NCT07383441	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT05136196	Map
IL	Illinois CancerCare-Peoria	Peoria61615	NCT07383441	Map
IL	OSF Children's Hospital of Illinois	Peoria61637	NCT05691478	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT05136196	Map
IL	Illinois CancerCare-Peru	Peru61354	NCT07383441	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT05136196	Map
IL	Illinois CancerCare-Princeton	Princeton61356	NCT07383441	Map
IL	UW Health Carbone Cancer Center Rockford	Rockford61114	NCT05327686	Map
IL	Memorial Hospital East	Shiloh62269	NCT06475989	Map
IL	Memorial Hospital East	Shiloh62269	NCT05136196	Map
IL	Memorial Hospital East	Shiloh62269	NCT06900595	Map
IL	Memorial Hospital East	Shiloh62269	NCT03866382	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT05136196	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT05327686	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT03866382	Map
IL	Southern Illinois University School of Medicine	Springfield62702	NCT07383441	Map
IL	Springfield Clinic	Springfield62702	NCT05136196	Map
IL	Springfield Clinic	Springfield62702	NCT05327686	Map
IL	Springfield Clinic	Springfield62702	NCT03866382	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT05136196	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT05327686	Map
IL	Springfield Memorial Hospital	Springfield62781	NCT03866382	Map
IL	Carle Cancer Center	Urbana61801	NCT05136196	Map
IL	Carle Cancer Center	Urbana61801	NCT05327686	Map
IL	Carle Cancer Center	Urbana61801	NCT06900595	Map
IL	Carle Cancer Center	Urbana61801	NCT03866382	Map
IL	Carle Cancer Center NCI Community Oncology Research Program	Urbana61801	NCT05168163	Map
IL	The Carle Foundation Hospital	Urbana61801	NCT05327686	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT06475989	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05773274	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05136196	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT05327686	Map
IL	Northwestern Medicine Cancer Center Warrenville	Warrenville60555	NCT06900595	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT05136196	Map
IL	Illinois CancerCare - Washington	Washington61571	NCT07383441	Map
IL	Rush-Copley Healthcare Center	Yorkville60560	NCT05136196	Map
IL	Research Site	Zion60099	NCT07011719	Map
IN	UChicago Medicine Northwest Indiana	Crown Point46307	NCT06475989	Map
IN	UChicago Medicine Northwest Indiana	Crown Point46307	NCT05327686	Map
IN	Franciscan Health Indianapolis	Indianapolis46237	NCT05327686	Map
IN	Research Site	Indianapolis46202	NCT07011719	Map
IN	Riley Hospital for Children	Indianapolis46202	NCT05691478	Map
IN	Franciscan Health Mooresville	Mooresville46158	NCT05327686	Map
IA	Mary Greeley Medical Center	Ames50010	NCT05136196	Map
IA	Mary Greeley Medical Center	Ames50010	NCT05327686	Map
IA	Mary Greeley Medical Center	Ames50010	NCT03866382	Map
IA	McFarland Clinic - Ames	Ames50010	NCT05136196	Map
IA	McFarland Clinic - Ames	Ames50010	NCT05327686	Map
IA	McFarland Clinic - Ames	Ames50010	NCT03866382	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05773274	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT05327686	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT06900595	Map
IA	UI Health Care Mission Cancer and Blood - Ankeny Clinic	Ankeny50023	NCT03866382	Map
IA	University of Iowa Healthcare Cancer Services Quad Cities	Bettendorf52722	NCT06475989	Map
IA	University of Iowa Healthcare Cancer Services Quad Cities	Bettendorf52722	NCT03866382	Map
IA	Saint Anthony Regional Hospital	Carroll51401	NCT06475989	Map
IA	Saint Anthony Regional Hospital	Carroll51401	NCT06900595	Map
IA	Mercy Hospital	Cedar Rapids52403	NCT06475989	Map
IA	Mercy Hospital	Cedar Rapids52403	NCT05136196	Map
IA	Mercy Hospital	Cedar Rapids52403	NCT07383441	Map
IA	Oncology Associates at Mercy Medical Center	Cedar Rapids52403	NCT06475989	Map
IA	Oncology Associates at Mercy Medical Center	Cedar Rapids52403	NCT05136196	Map
IA	Oncology Associates at Mercy Medical Center	Cedar Rapids52403	NCT07383441	Map
IA	Mercy Cancer Center-West Lakes	Clive50325	NCT06475989	Map
IA	Mercy Cancer Center-West Lakes	Clive50325	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05773274	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT05327686	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT06900595	Map
IA	UI Health Care Mission Cancer and Blood - West Des Moines Clinic	Clive50325	NCT03866382	Map
IA	Heartland Oncology and Hematology LLP	Council Bluffs51503	NCT06475989	Map
IA	Methodist Jennie Edmundson Hospital	Council Bluffs51503	NCT06475989	Map
IA	Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ	Council Bluffs51503	NCT06475989	Map
IA	Greater Regional Medical Center	Creston50801	NCT06475989	Map
IA	Blank Children's Hospital	Des Moines50309	NCT05691478	Map
IA	Broadlawns Medical Center	Des Moines50314	NCT06475989	Map
IA	Broadlawns Medical Center	Des Moines50314	NCT06900595	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT06475989	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT05773274	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT05327686	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT06900595	Map
IA	Iowa Methodist Medical Center	Des Moines50309	NCT03866382	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT06475989	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT05136196	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT06900595	Map
IA	Mercy Medical Center - Des Moines	Des Moines50314	NCT03866382	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05773274	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT05327686	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT06900595	Map
IA	UI Health Care Mission Cancer and Blood - Des Moines Clinic	Des Moines50309	NCT03866382	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05773274	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT05327686	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT06900595	Map
IA	UI Health Care Mission Cancer and Blood - Laurel Clinic	Des Moines50314	NCT03866382	Map
IA	McFarland Clinic - Trinity Cancer Center	Fort Dodge50501	NCT05136196	Map
IA	McFarland Clinic - Trinity Cancer Center	Fort Dodge50501	NCT03866382	Map
IA	UI Healthcare Mission Cancer and Blood - Fort Dodge	Fort Dodge50501	NCT06475989	Map
IA	UI Healthcare Mission Cancer and Blood - Fort Dodge	Fort Dodge50501	NCT06900595	Map
IA	University of Iowa Hospitals & Clinics	Iowa City52242	NCT06026410	Map
IA	University of Iowa/Holden Comprehensive Cancer Center	Iowa City52242	NCT06475989	Map
IA	University of Iowa/Holden Comprehensive Cancer Center	Iowa City52242	NCT05691478	Map
IA	University of Iowa/Holden Comprehensive Cancer Center	Iowa City52242	NCT03866382	Map
IA	McFarland Clinic - Marshalltown	Marshalltown50158	NCT05136196	Map
IA	McFarland Clinic - Marshalltown	Marshalltown50158	NCT03866382	Map
IA	UI Healthcare Mission Cancer and Blood - Pella	Pella50219	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT06475989	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05773274	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05136196	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT05327686	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT06900595	Map
IA	UI Health Care Mission Cancer and Blood - Waukee Clinic	Waukee50263	NCT03866382	Map
IA	Mercy Medical Center-West Lakes	West Des Moines50266	NCT06475989	Map
IA	The Iowa Clinic PC	West Des Moines50266	NCT06475989	Map
KS	University of Kansas Clinical Research Center	Fairway66205	NCT03816345	Map
KS	Central Care Cancer Center - Garden City	Garden City67846	NCT06475989	Map
KS	Central Care Cancer Center - Great Bend	Great Bend67530	NCT06475989	Map
KS	HaysMed	Hays67601	NCT03816345	Map
KS	HaysMed	Hays67601	NCT03866382	Map
KS	University of Kansas Cancer Center	Kansas City66160	NCT03816345	Map
KS	Lawrence Memorial Hospital	Lawrence66044	NCT03816345	Map
KS	Lawrence Memorial Hospital	Lawrence66044	NCT03866382	Map
KS	The University of Kansas Cancer Center - Olathe	Olathe66061	NCT03816345	Map
KS	The University of Kansas Cancer Center - Olathe	Olathe66061	NCT03866382	Map
KS	University of Kansas Cancer Center-Overland Park	Overland Park66210	NCT03816345	Map
KS	University of Kansas Hospital-Indian Creek Campus	Overland Park66211	NCT03816345	Map
KS	Freeman Physician Group of Pittsburg	Pittsburg66762	NCT03866382	Map
KS	Mercy Hospital Pittsburg	Pittsburg66762	NCT06475989	Map
KS	Salina Regional Health Center	Salina67401	NCT03816345	Map
KS	Salina Regional Health Center	Salina67401	NCT03866382	Map
KS	University of Kansas Health System Saint Francis Campus	Topeka66606	NCT03816345	Map
KS	University of Kansas Health System Saint Francis Campus	Topeka66606	NCT03866382	Map
KS	University of Kansas Hospital-Westwood Cancer Center	Westwood66205	NCT03816345	Map
KS	University of Kansas Hospital-Westwood Cancer Center	Westwood66205	NCT03866382	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT06475989	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT03816345	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT05691478	Map
KY	University of Kentucky/Markey Cancer Center	Lexington40536	NCT03866382	Map
KY	Norton Children's Hospital	Louisville40202	NCT05691478	Map
KY	Research Site	Louisville40207	NCT07011719	Map
KY	Research Site	Louisville40202	NCT05536141	Map
KY	University of Louisville-James Graham Brown Cancer Center	Louisville40202	NCT03899155	Map
LA	Louisiana Hematology Oncology Associates LLC	Baton Rouge70809	NCT05327686	Map
LA	Louisiana Hematology Oncology Associates LLC	Baton Rouge70809	NCT03866382	Map
LA	Mary Bird Perkins Cancer Center	Baton Rouge70809	NCT05327686	Map
LA	Northshore Oncology Associates-Covington	Covington70433	NCT03866382	Map
LA	Research Site	Jefferson70121	NCT07011719	Map
LA	Mary Bird Perkins Cancer Center - Metairie	Metairie70002	NCT05327686	Map
LA	Mary Bird Perkins Cancer Center - Metairie	Metairie70002	NCT03866382	Map
LA	Children's Hospital New Orleans	New Orleans70118	NCT05691478	Map
LA	Ochsner Medical Center Jefferson	New Orleans70121	NCT05691478	Map
LA	Research Site	New Orleans70121	NCT05536141	Map
LA	University Medical Center New Orleans	New Orleans70112	NCT05168163	Map
ME	Eastern Maine Medical Center	Bangor04401	NCT05691478	Map
ME	Maine Children's Cancer Program	Scarborough04074	NCT05691478	Map
ME	New England Cancer Specialists ( Site 0132)	Westbrook04092	NCT07227402	Map
MD	Greater Baltimore Medical Center ( Site 0145)	Baltimore21204	NCT07227402	Map
MD	Johns Hopkins Hospital	Baltimore21287	NCT07293351	Map
MD	Johns Hopkins University (Data Collection Only)	Baltimore21287	NCT06835972	Map
MD	Johns Hopkins University/Sidney Kimmel Cancer Center	Baltimore21287	NCT03816345	Map
MD	Johns Hopkins University/Sidney Kimmel Cancer Center	Baltimore21287	NCT05691478	Map
MD	Research Site	Baltimore21287	NCT07011719	Map
MD	Research Site	Baltimore21287	NCT05536141	Map
MD	Sinai Hospital of Baltimore	Baltimore21215	NCT05691478	Map
MD	University of Maryland/Greenebaum Cancer Center	Baltimore21201	NCT06475989	Map
MD	University of Maryland/Greenebaum Cancer Center	Baltimore21201	NCT05691478	Map
MD	National Cancer Institute Developmental Therapeutics Clinic	Bethesda20892	NCT03816345	Map
MD	National Institutes of Health Clinical Center	Bethesda20892	NCT03866382	Map
MD	Walter Reed National Military Medical Center	Bethesda20889-5600	NCT05691478	Map
MD	FMH James M Stockman Cancer Institute	Frederick21702	NCT03866382	Map
MA	Beth Israel Deaconess Medical Center ( Site 0107)	Boston02215	NCT07405164	Map
MA	Brigham and Women's Hospital	Boston02115	NCT05327686	Map
MA	Dana_Farber Cancer Institute (DFCI)	Boston02215	NCT03899155	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT03816345	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT06026410	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT05327686	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT05691478	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT06900595	Map
MA	Dana-Farber Cancer Institute	Boston02215	NCT05019703	Map
MA	Dana-Farber Cancer Institute ( Site 0105)	Boston02215	NCT07405164	Map
MA	Massachusetts General Hospital Cancer Center	Boston02114	NCT03816345	Map
MA	Massachusetts General Hospital Cancer Center	Boston02114	NCT05327686	Map
MA	Massachusetts General Hospital Cancer Center	Boston02114	NCT05691478	Map
MA	Research Site	Boston02114	NCT07011719	Map
MA	Research Site	Boston02215	NCT07011719	Map
MA	Research Site	Boston02215	NCT05536141	Map
MA	Lahey Clinic	Burlington01805	NCT03866382	Map
MA	Lahey Hospital and Medical Center	Burlington01805	NCT07383441	Map
MA	Lahey Clinic Peabody	Peabody01960	NCT03866382	Map
MA	Lahey Medical Center-Peabody	Peabody01960	NCT07383441	Map
MA	Baystate Medical Center	Springfield01199	NCT05136196	Map
MA	UMass Memorial Medical Center - University Campus	Worcester01655	NCT05691478	Map
MI	MyMichigan Medical Center Gratiot	Alma48801	NCT06475989	Map
MI	MyMichigan Medical Center Alpena	Alpena49707	NCT06475989	Map
MI	C S Mott Children's Hospital	Ann Arbor48109	NCT05691478	Map
MI	Michigan Cancer Research Consortium NCORP	Ann Arbor48106	NCT05168163	Map
MI	Trinity Health IHA - Obstetrics and Gynecology West Arbor	Ann Arbor48103	NCT06475989	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT06475989	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT05136196	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT05327686	Map
MI	Trinity Health Saint Joseph Mercy Hospital Ann Arbor	Ann Arbor48106	NCT03866382	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT06475989	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT05136196	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT05327686	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT05691478	Map
MI	University of Michigan Rogel Cancer Center	Ann Arbor48109	NCT06900595	Map
MI	Bronson Battle Creek	Battle Creek49017	NCT05136196	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT06475989	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT05136196	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT05327686	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Brighton	Brighton48114	NCT07383441	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT06475989	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT05136196	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT05327686	Map
MI	Trinity Health Medical Center - Brighton	Brighton48114	NCT03866382	Map
MI	University of Michigan - Brighton Center for Specialty Care	Brighton48116	NCT06475989	Map
MI	Henry Ford Cancer Institute-Downriver	Brownstown48183	NCT05691478	—
MI	Henry Ford Cancer Institute-Downriver	Brownstown48183	NCT03866382	—
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT06475989	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT05136196	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT05327686	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Canton	Canton48188	NCT07383441	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT06475989	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT05136196	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT05327686	Map
MI	Trinity Health Medical Center - Canton	Canton48188	NCT03866382	Map
MI	Chelsea Hospital	Chelsea48118	NCT06475989	Map
MI	Chelsea Hospital	Chelsea48118	NCT05136196	Map
MI	Chelsea Hospital	Chelsea48118	NCT05327686	Map
MI	Chelsea Hospital	Chelsea48118	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT06475989	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT05136196	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT05327686	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital	Chelsea48118	NCT07383441	Map
MI	Hematology Oncology Consultants-Clarkston	Clarkston48346	NCT06475989	Map
MI	Hematology Oncology Consultants-Clarkston	Clarkston48346	NCT03866382	Map
MI	Newland Medical Associates-Clarkston	Clarkston48346	NCT06475989	Map
MI	Henry Ford Macomb Hospital-Clinton Township	Clinton Township48038	NCT05691478	Map
MI	Henry Ford Macomb Hospital-Clinton Township	Clinton Township48038	NCT03866382	Map
MI	Corewell Health Dearborn Hospital	Dearborn48124	NCT05327686	Map
MI	Henry Ford Medical Center-Fairlane	Dearborn48126	NCT05691478	Map
MI	Henry Ford Medical Center-Fairlane	Dearborn48126	NCT03866382	Map
MI	Children's Hospital of Michigan	Detroit48201	NCT05691478	Map
MI	Henry Ford Health Saint John Hospital	Detroit48236	NCT06475989	Map
MI	Henry Ford Health Saint John Hospital	Detroit48236	NCT03866382	Map
MI	Henry Ford Health System	Detroit48202	NCT06026410	Map
MI	Henry Ford Hospital	Detroit48202	NCT05773274	Map
MI	Henry Ford Hospital	Detroit48202	NCT05691478	Map
MI	Henry Ford Hospital	Detroit48202	NCT03866382	Map
MI	Karmanos Cancer Center ( Site 0108)	Detroit48201	NCT07405164	Map
MI	Research Site	Detroit48201	NCT05536141	Map
MI	Research Site	Detroit48202	NCT05536141	Map
MI	Henry Ford River District Hospital	East China48054	NCT06475989	—
MI	Henry Ford River District Hospital	East China Township48054	NCT03866382	—
MI	OSF Saint Francis Hospital and Medical Group	Escanaba49829	NCT05136196	Map
MI	Corewell Health Farmington Hills Hospital	Farmington Hills48336	NCT05327686	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT06475989	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT05136196	Map
MI	Cancer Hematology Centers - Flint	Flint48503	NCT03866382	Map
MI	Genesee Hematology Oncology PC	Flint48503	NCT06475989	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT06475989	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT05136196	Map
MI	Genesys Hurley Cancer Institute	Flint48503	NCT03866382	Map
MI	Hurley Medical Center	Flint48503	NCT06475989	Map
MI	Hurley Medical Center	Flint48503	NCT05136196	Map
MI	Hurley Medical Center	Flint48503	NCT03866382	Map
MI	MyMichigan Medical Center Gladwin	Gladwin48624	NCT06475989	Map
MI	Corewell Health Grand Rapids Hospitals - Butterworth Hospital	Grand Rapids49503	NCT05136196	Map
MI	Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital	Grand Rapids49503	NCT05691478	Map
MI	Trinity Health Grand Rapids Hospital	Grand Rapids49503	NCT05136196	Map
MI	Henry Ford Saint John Hospital - Academic	Grosse Pointe Woods48236	NCT06475989	Map
MI	Henry Ford Saint John Hospital - Academic	Grosse Pointe Woods48236	NCT03866382	Map
MI	Henry Ford Saint John Hospital - Breast	Grosse Pointe Woods48236	NCT06475989	Map
MI	Henry Ford Saint John Hospital - Van Elslander	Grosse Pointe Woods48236	NCT06475989	Map
MI	Henry Ford Saint John Hospital - Van Elslander	Grosse Pointe Woods48236	NCT03866382	Map
MI	Allegiance Health	Jackson49201	NCT05691478	Map
MI	Allegiance Health	Jackson49201	NCT03866382	Map
MI	Beacon Kalamazoo Cancer Center	Kalamazoo49009	NCT05136196	Map
MI	Bronson Methodist Hospital	Kalamazoo49007	NCT05136196	Map
MI	Bronson Methodist Hospital	Kalamazoo49007	NCT05691478	Map
MI	West Michigan Cancer Center	Kalamazoo49007	NCT05136196	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT06475989	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT05136196	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT05327686	Map
MI	University of Michigan Health - Sparrow Lansing	Lansing48912	NCT03866382	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT06475989	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT05136196	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT05327686	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT03866382	Map
MI	Trinity Health Saint Mary Mercy Livonia Hospital	Livonia48154	NCT07383441	Map
MI	Henry Ford Saint John Hospital - Macomb Medical	Macomb48044	NCT06475989	Map
MI	Henry Ford Saint John Hospital - Macomb Medical	Macomb48044	NCT03866382	Map
MI	Henry Ford Warren Hospital - Breast Macomb	Macomb48044	NCT06475989	Map
MI	MyMichigan Medical Center Midland	Midland48670	NCT06475989	Map
MI	MyMichigan Medical Center Mount Pleasant	Mount Pleasant48858	NCT06475989	Map
MI	Trinity Health Muskegon Hospital	Muskegon49444	NCT05136196	Map
MI	Corewell Health Lakeland Hospitals - Niles Hospital	Niles49120	NCT05136196	Map
MI	Cancer and Hematology Centers of Western Michigan - Norton Shores	Norton Shores49444	NCT05136196	Map
MI	Henry Ford Medical Center-Columbus	Novi48377	NCT05691478	Map
MI	Henry Ford Medical Center-Columbus	Novi48377	NCT03866382	Map
MI	Hope Cancer Center	Pontiac48341	NCT06475989	Map
MI	Michigan Healthcare Professionals Pontiac	Pontiac48341	NCT06475989	Map
MI	Michigan Healthcare Professionals Pontiac	Pontiac48341	NCT03866382	Map
MI	Newland Medical Associates-Pontiac	Pontiac48341	NCT06475989	Map
MI	Newland Medical Associates-Pontiac	Pontiac48341	NCT03866382	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT06475989	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT05136196	Map
MI	Trinity Health Saint Joseph Mercy Oakland Hospital	Pontiac48341	NCT03866382	Map
MI	Corewell Health Reed City Hospital	Reed City49677	NCT05136196	Map
MI	Corewell Health Children's	Royal Oak48073	NCT05691478	Map
MI	Corewell Health William Beaumont University Hospital	Royal Oak48073	NCT05327686	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT06475989	Map
MI	MyMichigan Medical Center Saginaw	Saginaw48601	NCT03866382	Map
MI	Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center	Saint Joseph49085	NCT05136196	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT06475989	Map
MI	MyMichigan Medical Center Tawas	Tawas City48764	NCT03866382	Map
MI	Munson Medical Center	Traverse City49684	NCT05136196	Map
MI	Corewell Health Beaumont Troy Hospital	Troy48085	NCT05327686	Map
MI	Henry Ford Health Warren Hospital	Warren48093	NCT06475989	Map
MI	Henry Ford Health Warren Hospital	Warren48093	NCT03866382	Map
MI	Henry Ford Madison Heights Hospital - Breast	Warren48093	NCT06475989	Map
MI	Henry Ford Warren Hospital - GLCMS	Warren48093	NCT06475989	Map
MI	Henry Ford Warren Hospital - GLCMS	Warren48093	NCT03866382	Map
MI	Henry Ford West Bloomfield Hospital	West Bloomfield48322	NCT05691478	Map
MI	Henry Ford West Bloomfield Hospital	West Bloomfield48322	NCT03866382	Map
MI	Henry Ford Wyandotte Hospital	Wyandotte48192	NCT05691478	Map
MI	Henry Ford Wyandotte Hospital	Wyandotte48192	NCT03866382	Map
MI	University of Michigan Health - West	Wyoming49519	NCT05136196	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT06475989	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT05136196	Map
MI	Huron Gastroenterology PC	Ypsilanti48106	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT06475989	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT05136196	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT05327686	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT03866382	Map
MI	Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus	Ypsilanti48197	NCT07383441	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT06475989	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT05136196	Map
MN	Sanford Joe Lueken Cancer Center	Bemidji56601	NCT05327686	Map
MN	Essentia Health Saint Joseph's Medical Center	Brainerd56401	NCT05136196	Map
MN	Essentia Health Saint Joseph's Medical Center	Brainerd56401	NCT05327686	Map
MN	Minnesota Oncology - Burnsville	Burnsville55337	NCT06475989	Map
MN	Minnesota Oncology - Burnsville	Burnsville55337	NCT05136196	Map
MN	Cambridge Medical Center	Cambridge55008	NCT06475989	Map
MN	Minnesota Oncology Hematology PA-Chaska	Chaska55318	NCT06475989	Map
MN	Minnesota Oncology Hematology PA-Chaska	Chaska55318	NCT05327686	Map
MN	Mercy Hospital	Coon Rapids55433	NCT06475989	Map
MN	Mercy Hospital	Coon Rapids55433	NCT05136196	Map
MN	Minnesota Oncology - Coon Rapids	Coon Rapids55433	NCT06475989	Map
MN	Essentia Health - Deer River Clinic	Deer River56636	NCT05136196	Map
MN	Essentia Health - Deer River Clinic	Deer River56636	NCT05327686	Map
MN	Essentia Health - Deer River Clinic	Deer River56636	NCT03866382	Map
MN	Essentia Health Saint Mary's - Detroit Lakes Clinic	Detroit Lakes56501	NCT05136196	Map
MN	Essentia Health Cancer Center	Duluth55805	NCT05136196	Map
MN	Essentia Health Cancer Center	Duluth55805	NCT05327686	Map
MN	Essentia Health Cancer Center	Duluth55805	NCT03866382	Map
MN	Essentia Health Saint Mary's Medical Center	Duluth55805	NCT05327686	Map
MN	Miller-Dwan Hospital	Duluth55805	NCT05327686	Map
MN	Fairview Southdale Hospital	Edina55435	NCT06475989	Map
MN	Fairview Southdale Hospital	Edina55435	NCT05136196	Map
MN	Fairview Southdale Hospital	Edina55435	NCT05327686	Map
MN	Fairview Southdale Hospital	Edina55435	NCT03866382	Map
MN	Minnesota Oncology - Edina	Edina55435	NCT06475989	Map
MN	Essentia Health - Fosston	Fosston56542	NCT05136196	Map
MN	Essentia Health Hibbing Clinic	Hibbing55746	NCT05136196	Map
MN	Essentia Health Hibbing Clinic	Hibbing55746	NCT05327686	Map
MN	Essentia Health Hibbing Clinic	Hibbing55746	NCT03866382	Map
MN	Fairview Clinics and Surgery Center Maple Grove	Maple Grove55369	NCT06475989	Map
MN	Fairview Clinics and Surgery Center Maple Grove	Maple Grove55369	NCT05327686	Map
MN	Minnesota Oncology - Maple Grove	Maple Grove55369	NCT06475989	Map
MN	Minnesota Oncology Hematology PA-Maplewood	Maplewood55109	NCT06475989	Map
MN	Saint John's Hospital - Healtheast	Maplewood55109	NCT06475989	Map
MN	Saint John's Hospital - Healtheast	Maplewood55109	NCT05136196	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT06475989	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT05136196	Map
MN	Abbott-Northwestern Hospital	Minneapolis55407	NCT05327686	Map
MN	Children's Hospitals and Clinics of Minnesota - Minneapolis	Minneapolis55404	NCT05691478	Map
MN	Health Partners Inc	Minneapolis55454	NCT06475989	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT06475989	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT05327686	Map
MN	Hennepin County Medical Center	Minneapolis55415	NCT03866382	Map
MN	University of Minnesota/Masonic Cancer Center	Minneapolis55455	NCT05327686	Map
MN	University of Minnesota/Masonic Cancer Center	Minneapolis55455	NCT05691478	Map
MN	Monticello Cancer Center	Monticello55362	NCT06475989	Map
MN	New Ulm Medical Center	New Ulm56073	NCT06475989	Map
MN	Essentia Health - Park Rapids	Park Rapids56470	NCT05136196	Map
MN	Fairview Northland Medical Center	Princeton55371	NCT06475989	Map
MN	North Memorial Medical Health Center	Robbinsdale55422	NCT06475989	Map
MN	Mayo Clinic Comprehensive Cancer Center	Rochester55905	NCT06026410	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT06475989	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05773274	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05136196	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05168163	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05327686	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT05691478	Map
MN	Mayo Clinic in Rochester	Rochester55905	NCT03866382	Map
MN	Research Site	Rochester55905	NCT07011719	Map
MN	Metro-Minnesota Community Clinical Oncology ( Site 0144)	Saint Louis Park55426	NCT07227402	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT06475989	Map
MN	Park Nicollet Clinic - Saint Louis Park	Saint Louis Park55416	NCT05136196	Map
MN	Regions Hospital	Saint Paul55101	NCT06475989	Map
MN	Regions Hospital	Saint Paul55101	NCT05136196	Map
MN	Regions Hospital	Saint Paul55101	NCT05327686	Map
MN	Regions Hospital	Saint Paul55101	NCT03866382	Map
MN	United Hospital	Saint Paul55102	NCT06475989	Map
MN	United Hospital	Saint Paul55102	NCT05136196	Map
MN	Essentia Health Sandstone	Sandstone55072	NCT05136196	Map
MN	Essentia Health Sandstone	Sandstone55072	NCT05327686	Map
MN	Essentia Health Sandstone	Sandstone55072	NCT03866382	Map
MN	Saint Francis Regional Medical Center	Shakopee55379	NCT06475989	Map
MN	Saint Francis Regional Medical Center	Shakopee55379	NCT05327686	Map
MN	Lakeview Hospital	Stillwater55082	NCT06475989	Map
MN	Lakeview Hospital	Stillwater55082	NCT05327686	Map
MN	Lakeview Hospital	Stillwater55082	NCT03866382	Map
MN	Sanford Thief River Falls Medical Center	Thief River Falls56701	NCT06475989	Map
MN	Essentia Health Virginia Clinic	Virginia55792	NCT05136196	Map
MN	Essentia Health Virginia Clinic	Virginia55792	NCT05327686	Map
MN	Essentia Health Virginia Clinic	Virginia55792	NCT03866382	Map
MN	Ridgeview Medical Center	Waconia55387	NCT06475989	Map
MN	Ridgeview Medical Center	Waconia55387	NCT05136196	Map
MN	Ridgeview Medical Center	Waconia55387	NCT05327686	Map
MN	Ridgeview Medical Center	Waconia55387	NCT03866382	Map
MN	Rice Memorial Hospital	Willmar56201	NCT06475989	Map
MN	Minnesota Oncology Hematology PA-Woodbury	Woodbury55125	NCT06475989	Map
MN	Minnesota Oncology Hematology PA-Woodbury	Woodbury55125	NCT05136196	Map
MN	Sanford Cancer Center Worthington	Worthington56187	NCT06475989	Map
MN	Fairview Lakes Medical Center	Wyoming55092	NCT06475989	Map
MS	Baptist Memorial Hospital and Cancer Center-Golden Triangle	Columbus39705	NCT07383441	Map
MS	Baptist Cancer Center-Grenada	Grenada38901	NCT07383441	Map
MS	University of Mississippi Medical Center	Jackson39216	NCT05691478	Map
MS	University of Mississippi Medical Center	Jackson39216	NCT03866382	Map
MS	Baptist Memorial Hospital and Cancer Center-Union County	New Albany38652	NCT07383441	Map
MS	Baptist Memorial Hospital and Cancer Center-Oxford	Oxford38655	NCT07383441	Map
MS	Baptist Memorial Hospital and Cancer Center-Desoto	Southhaven38671	NCT07383441	Map
MO	Mercy Oncology and Hematology - Clayton-Clarkson	Ballwin63011	NCT06475989	Map
MO	Central Care Cancer Center - Bolivar	Bolivar65613	NCT06475989	Map
MO	Cox Cancer Center Branson	Branson65616	NCT06475989	Map
MO	Mercy Cancer Center - Cape Girardeau	Cape Girardeau63703	NCT06475989	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT05136196	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT05327686	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT03866382	Map
MO	Saint Francis Medical Center	Cape Girardeau63703	NCT07383441	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT06475989	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT03816345	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT05136196	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT06900595	Map
MO	Siteman Cancer Center at Saint Peters Hospital	City of Saint Peters63376	NCT03866382	Map
MO	MU Health - University Hospital/Ellis Fischel Cancer Center	Columbia65212	NCT05327686	Map
MO	University of Missouri Children's Hospital	Columbia65212	NCT05691478	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT06475989	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT03816345	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT05136196	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT06900595	Map
MO	Siteman Cancer Center at West County Hospital	Creve Coeur63141	NCT03866382	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT03866382	Map
MO	Parkland Health Center - Farmington	Farmington63640	NCT07383441	Map
MO	Freeman Health System	Joplin64804	NCT06475989	Map
MO	Mercy Hospital Joplin	Joplin64804	NCT06475989	Map
MO	Children's Mercy Hospitals and Clinics	Kansas City64108	NCT05691478	Map
MO	Children's Mercy Hospitals and Clinics	Kansas City64108	NCT06900595	Map
MO	University Health Truman Medical Center	Kansas City64108	NCT03816345	Map
MO	University Health Truman Medical Center	Kansas City64108	NCT03866382	Map
MO	University of Kansas Cancer Center - North	Kansas City64154	NCT03816345	Map
MO	University of Kansas Cancer Center - Lee's Summit	Lee's Summit64064	NCT03816345	Map
MO	University of Kansas Cancer Center - Lee's Summit	Lee's Summit64064	NCT03866382	Map
MO	University of Kansas Cancer Center at North Kansas City Hospital	North Kansas City64116	NCT03816345	Map
MO	Lake Regional Hospital	Osage Beach65065	NCT06475989	Map
MO	Mercy Clinic-Rolla-Cancer and Hematology	Rolla65401	NCT06475989	Map
MO	Phelps Health Delbert Day Cancer Institute	Rolla65401	NCT06475989	Map
MO	Heartland Regional Medical Center	Saint Joseph64506	NCT06475989	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT03866382	Map
MO	Sainte Genevieve County Memorial Hospital	Sainte Genevieve63670	NCT07383441	Map
MO	CoxHealth South Hospital	Springfield65807	NCT06475989	Map
MO	CoxHealth South Hospital	Springfield65807	NCT06900595	Map
MO	Mercy Hospital Springfield	Springfield65804	NCT06475989	Map
MO	Mercy Hospital Springfield	Springfield65804	NCT05327686	Map
MO	Cardinal Glennon Children's Medical Center	St Louis63104	NCT05691478	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT06475989	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT05327686	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT05691478	Map
MO	Mercy Hospital Saint Louis	St Louis63141	NCT03866382	Map
MO	Mercy Hospital South	St Louis63128	NCT06475989	Map
MO	Mercy Hospital South	St Louis63128	NCT05136196	Map
MO	Mercy Hospital South	St Louis63128	NCT05327686	Map
MO	Mercy Hospital South	St Louis63128	NCT03866382	Map
MO	Mercy Infusion Center - Chippewa	St Louis63109	NCT06475989	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT03866382	Map
MO	Missouri Baptist Medical Center	St Louis63131	NCT07383441	Map
MO	Research Site	St Louis63110	NCT07011719	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT06475989	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT03816345	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT05136196	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT06900595	Map
MO	Siteman Cancer Center at Christian Hospital	St Louis63136	NCT03866382	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT06475989	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT03816345	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT05136196	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT06900595	Map
MO	Siteman Cancer Center-South County	St Louis63129	NCT03866382	Map
MO	Washington University School of Medicine	St Louis63110	NCT06475989	Map
MO	Washington University School of Medicine	St Louis63110	NCT03816345	Map
MO	Washington University School of Medicine	St Louis63110	NCT05136196	Map
MO	Washington University School of Medicine	St Louis63110	NCT06026410	Map
MO	Washington University School of Medicine	St Louis63110	NCT05691478	Map
MO	Washington University School of Medicine	St Louis63110	NCT06900595	Map
MO	Washington University School of Medicine	St Louis63110	NCT03866382	Map
MO	Washington University School of Medicine	St Louis63110	NCT07293351	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT03866382	Map
MO	Missouri Baptist Sullivan Hospital	Sullivan63080	NCT07383441	Map
MO	BJC Outpatient Center at Sunset Hills	Sunset Hills63127	NCT03866382	Map
MO	Mercy Hospital Washington	Washington63090	NCT06475989	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT06475989	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT05136196	Map
MT	Community Hospital of Anaconda	Anaconda59711	NCT03866382	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT06475989	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT05136196	Map
MT	Billings Clinic Cancer Center	Billings59101	NCT03866382	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT06475989	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT05136196	Map
MT	Bozeman Health Deaconess Hospital	Bozeman59715	NCT03866382	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT06475989	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT05136196	Map
MT	Benefis Sletten Cancer Institute	Great Falls59405	NCT03866382	Map
MT	Great Falls Clinic	Great Falls59405	NCT06475989	Map
MT	Hi-Line Sletten Cancer Center	Havre59501	NCT06475989	Map
MT	Benefis Helena Specialty Center	Helena59601	NCT06475989	Map
MT	Logan Health Medical Center	Kalispell59901	NCT06475989	Map
MT	Logan Health Medical Center	Kalispell59901	NCT05136196	Map
MT	Logan Health Medical Center	Kalispell59901	NCT03866382	Map
MT	Community Medical Center	Missoula59804	NCT06475989	Map
MT	Community Medical Center	Missoula59804	NCT05136196	Map
MT	Community Medical Center	Missoula59804	NCT03866382	Map
MT	Saint Patrick Hospital - Community Hospital	Missoula59802	NCT06475989	Map
NE	Nebraska Medicine-Bellevue	Bellevue68123	NCT05136196	Map
NE	Nebraska Medicine-Bellevue	Bellevue68123	NCT05327686	Map
NE	Nebraska Medicine-Bellevue	Bellevue68123	NCT06900595	Map
NE	Nebraska Medicine-Bellevue	Bellevue68123	NCT03866382	Map
NE	Children's Hospital and Medical Center of Omaha	Omaha68114	NCT05691478	Map
NE	Nebraska Cancer Specialists/Oncology Hematology West PC - MECC	Omaha68114	NCT06475989	Map
NE	Nebraska Medicine-Village Pointe	Omaha68118	NCT05136196	Map
NE	Nebraska Medicine-Village Pointe	Omaha68118	NCT05327686	Map
NE	Nebraska Medicine-Village Pointe	Omaha68118	NCT06900595	Map
NE	Nebraska Medicine-Village Pointe	Omaha68118	NCT03866382	Map
NE	Nebraska Methodist Hospital	Omaha68114	NCT06475989	Map
NE	Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0131)	Omaha68130-2042	NCT07227402	Map
NE	Research Site	Omaha68198	NCT07011719	Map
NE	Research Site	Omaha68124	NCT05536141	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT05136196	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT05327686	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT05691478	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT06900595	Map
NE	University of Nebraska Medical Center	Omaha68198	NCT03866382	Map
NV	Alliance for Childhood Diseases/Cure 4 the Kids Foundation	Las Vegas89135	NCT05691478	Map
NV	OptumCare Cancer Care at Charleston	Las Vegas89102	NCT03866382	Map
NV	OptumCare Cancer Care at Fort Apache	Las Vegas89183	NCT03866382	Map
NV	Summerlin Hospital Medical Center	Las Vegas89144	NCT05691478	Map
NH	Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center	Lebanon03756	NCT05136196	Map
NH	Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center	Lebanon03756	NCT05691478	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT01639508	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT05327686	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT06900595	Map
NJ	Memorial Sloan Kettering Basking Ridge	Basking Ridge07920	NCT03866382	Map
NJ	Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)	Basking Ridge07920	NCT06835972	Map
NJ	Cooper Hospital University Medical Center	Camden08103	NCT05327686	Map
NJ	Hackensack University Medical Center	Hackensack07601	NCT05691478	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT01639508	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT05327686	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT06900595	Map
NJ	Memorial Sloan Kettering Monmouth	Middletown07748	NCT03866382	Map
NJ	Memorial Sloan Kettering Monmouth (Limited Protocol Activities)	Middletown07748	NCT06835972	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT01639508	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT05327686	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT06900595	Map
NJ	Memorial Sloan Kettering Bergen	Montvale07645	NCT03866382	Map
NJ	Memorial Sloan Kettering Bergen (Limited Protocol Activities)	Montvale07645	NCT06835972	Map
NJ	Morristown Medical Center	Morristown07960	NCT05691478	Map
NJ	Cooper CyberKnife Center	Mount Laurel08054	NCT05327686	Map
NJ	Research Site	New Brunswick08903	NCT07011719	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08903	NCT03816345	Map
NJ	Rutgers Cancer Institute of New Jersey	New Brunswick08901	NCT06026410	Map
NJ	Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital	New Brunswick08903	NCT05691478	Map
NJ	Newark Beth Israel Medical Center	Newark07112	NCT05691478	Map
NJ	Saint Joseph's Regional Medical Center	Paterson07503	NCT05691478	Map
NM	Lovelace Medical Center-Saint Joseph Square	Albuquerque87102	NCT05327686	Map
NM	Lovelace Radiation Oncology	Albuquerque87109	NCT05327686	Map
NM	University of New Mexico Cancer Center	Albuquerque87106	NCT05136196	Map
NY	Albany Medical Center	Albany12208	NCT05691478	Map
NY	Northwell Health Imbert Cancer Center	Bay Shore11706	NCT05327686	Map
NY	Research Site	Buffalo14263	NCT07011719	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT05168163	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT05691478	Map
NY	Roswell Park Cancer Institute	Buffalo14263	NCT03899155	Map
NY	Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities)	Commack11725	NCT06835972	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT01639508	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT05327686	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT06900595	Map
NY	Memorial Sloan Kettering Commack	Commack11725	NCT03866382	Map
NY	Glens Falls Hospital	Glens Falls12801	NCT05327686	Map
NY	Northwell Health Cancer Institute at Huntington	Greenlawn11740	NCT05327686	Map
NY	Memorial Sloan Kettering West Harrison (Limited Protocol Activities)	Harrison10604	NCT06835972	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT01639508	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT05327686	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT06900595	Map
NY	Memorial Sloan Kettering Westchester	Harrison10604	NCT03866382	Map
NY	Memorial Sloan Kettering Cancer Center	Hauppauge11788	NCT07293351	Map
NY	Northwell Health/Center for Advanced Medicine	Lake Success11042	NCT05327686	Map
NY	NYU Langone Hematology Oncology Associates-Mineola	Mineola11501	NCT03899155	Map
NY	NYU Langone Hospital - Long Island	Mineola11501	NCT03816345	Map
NY	NYU Langone Hospital - Long Island	Mineola11501	NCT05136196	Map
NY	NYU Langone Hospital - Long Island	Mineola11501	NCT05691478	Map
NY	NYU Langone Hospital - Long Island	Mineola11501	NCT03866382	Map
NY	Northern Westchester Hospital	Mount Kisco10549	NCT05327686	Map
NY	The Steven and Alexandra Cohen Children's Medical Center of New York	New Hyde Park11040	NCT05691478	Map
NY	Icahn School of Medicine at Mount Sinai	New York10029	NCT05188118	Map
NY	Laura and Isaac Perlmutter Cancer Center at NYU Langone	New York10016	NCT03816345	Map
NY	Laura and Isaac Perlmutter Cancer Center at NYU Langone	New York10016	NCT05136196	Map
NY	Laura and Isaac Perlmutter Cancer Center at NYU Langone	New York10016	NCT05327686	Map
NY	Laura and Isaac Perlmutter Cancer Center at NYU Langone	New York10016	NCT05691478	Map
NY	Lenox Hill Hospital	New York10075	NCT05327686	Map
NY	Manhattan Eye Ear and Throat Hospital	New York10065	NCT05327686	Map
NY	Memorial Sloan Kettering Cancer Center	New York100653	NCT05425004	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT01639508	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT05327686	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT05691478	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT06900595	Map
NY	Memorial Sloan Kettering Cancer Center	New York10065	NCT03866382	Map
NY	Memorial Sloan Kettering Cancer Center (All Protocol Activites)	New York10065	NCT06835972	Map
NY	NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center	New York10032	NCT03816345	Map
NY	NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center	New York10032	NCT05691478	Map
NY	NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center	New York10032	NCT03866382	Map
NY	NYP/Weill Cornell Medical Center	New York10065	NCT03816345	Map
NY	NYP/Weill Cornell Medical Center	New York10065	NCT05691478	Map
NY	NYP/Weill Cornell Medical Center	New York10065	NCT03866382	Map
NY	Research Site	New York10029	NCT05536141	Map
NY	Research Site	New York10065	NCT05536141	Map
NY	Research Site	Rochester14642	NCT07011719	Map
NY	University of Rochester	Rochester14642	NCT05773274	Map
NY	University of Rochester	Rochester14642	NCT05691478	Map
NY	Phelps Memorial Hospital Center	Sleepy Hollow10591	NCT05327686	Map
NY	Stony Brook University Medical Center	Stony Brook11794	NCT05691478	Map
NY	State University of New York Upstate Medical University	Syracuse13210	NCT05691478	Map
NY	Children's Hospital at Montefiore	The Bronx10467	NCT05135975	Map
NY	Montefiore Medical Center	The Bronx10467	NCT07194044	Map
NY	Montefiore Medical Center - Moses Campus	The Bronx10467	NCT05691478	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT01639508	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT05327686	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT06900595	Map
NY	Memorial Sloan Kettering Nassau	Uniondale11553	NCT03866382	Map
NY	Memorial Sloan Kettering Nassau (Limited Protocol Activities)	Uniondale11553	NCT06835972	Map
NY	New York Medical College	Valhalla10595	NCT05691478	Map
NC	Duke Cancer Center Cary	Cary27518	NCT05327686	Map
NC	Duke Cancer Center Cary	Cary27518	NCT06900595	Map
NC	Research Site	Chapel Hill27514	NCT07011719	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT06475989	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT05327686	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT05691478	Map
NC	UNC Lineberger Comprehensive Cancer Center	Chapel Hill27599	NCT03866382	Map
NC	Atrium Health Pineville/LCI-Pineville	Charlotte28210	NCT05327686	Map
NC	Atrium Health Pineville/LCI-Pineville	Charlotte28210	NCT05691478	Map
NC	Atrium Health University City/LCI-University	Charlotte28262	NCT05327686	Map
NC	Carolina Oncology Specialists, PA ( Site 9002)	Charlotte28207	NCT07227402	Map
NC	Carolinas Medical Center/Levine Cancer Institute	Charlotte28203	NCT05327686	Map
NC	Carolinas Medical Center/Levine Cancer Institute	Charlotte28203	NCT05691478	Map
NC	Levine Cancer Institute	Charlotte28204	NCT05797805	Map
NC	Levine Cancer Institute-Ballantyne	Charlotte28277	NCT05327686	Map
NC	Novant Health Presbyterian Medical Center	Charlotte28204	NCT05691478	Map
NC	Wake Forest University at Clemmons	Clemmons27012	NCT05327686	Map
NC	Southeastern Medical Oncology Center-Clinton	Clinton28328	NCT05136196	Map
NC	Atrium Health Cabarrus/LCI-Concord	Concord28025	NCT05327686	Map
NC	Duke University Medical Center	Durham27710	NCT06475989	Map
NC	Duke University Medical Center	Durham27710	NCT05327686	Map
NC	Duke University Medical Center	Durham27710	NCT05691478	Map
NC	Duke University Medical Center	Durham27710	NCT06900595	Map
NC	Research Site	Durham27710	NCT07011719	Map
NC	Levine Cancer Institute-Gaston	Gastonia28054	NCT05327686	Map
NC	Southeastern Medical Oncology Center-Goldsboro	Goldsboro27534	NCT05136196	Map
NC	East Carolina University	Greenville27834	NCT05691478	Map
NC	Margaret R Pardee Memorial Hospital	Hendersonville28791	NCT03866382	Map
NC	Hayworth Cancer Center	High Point27262	NCT05327686	Map
NC	Southeastern Medical Oncology Center-Jacksonville	Jacksonville28546	NCT05136196	Map
NC	Atrium Health Union/LCI-Union	Monroe28112	NCT05327686	Map
NC	Duke Cancer Center Raleigh	Raleigh27609	NCT05327686	Map
NC	Duke Cancer Center Raleigh	Raleigh27609	NCT06900595	Map
NC	Wake Forest Baptist Health - Wilkes Medical Center	Wilkesboro28659	NCT05327686	Map
NC	Wake Forest University Health Sciences	Winston-Salem27157	NCT05327686	Map
NC	Wake Forest University Health Sciences	Winston-Salem27157	NCT05691478	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT06475989	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT05136196	Map
ND	Sanford Bismarck Medical Center	Bismarck58501	NCT05327686	Map
ND	Essentia Health Cancer Center-South University Clinic	Fargo58103	NCT05136196	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT06475989	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05136196	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05327686	Map
ND	Sanford Broadway Medical Center	Fargo58122	NCT05691478	Map
ND	Sanford Medical Center Fargo	Fargo58104	NCT06475989	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT06475989	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT05136196	Map
ND	Sanford Roger Maris Cancer Center	Fargo58122	NCT05327686	Map
ND	Sanford South University Medical Center	Fargo58103	NCT06475989	Map
ND	Southpointe-Sanford Medical Center Fargo	Fargo58103	NCT06475989	Map
ND	Essentia Health - Jamestown Clinic	Jamestown58401	NCT05136196	Map
OH	Children's Hospital Medical Center of Akron	Akron44308	NCT05691478	Map
OH	UH Seidman Cancer Center at UH Avon Health Center	Avon44011	NCT05327686	Map
OH	UHHS-Chagrin Highlands Medical Center	Beachwood44122	NCT05327686	Map
OH	Strecker Cancer Center-Belpre	Belpre45714	NCT03866382	Map
OH	Miami Valley Hospital South	Centerville45459	NCT05136196	Map
OH	Miami Valley Hospital South	Centerville45459	NCT05327686	Map
OH	Adena Regional Medical Center	Chillicothe45601	NCT03866382	Map
OH	Cincinnati Children's Hospital Medical Center	Cincinnati45229	NCT05691478	Map
OH	Oncology Hematology Care	Cincinnati45242	NCT03899155	Map
OH	University of Cincinnati Cancer Center-UC Medical Center	Cincinnati45219	NCT05327686	Map
OH	Case Western Reserve University	Cleveland44106	NCT05327686	Map
OH	Cleveland Clinic	Cleveland44195	NCT05361720	Map
OH	Cleveland Clinic	Cleveland44195	NCT07293351	Map
OH	Cleveland Clinic Foundation	Cleveland44195	NCT05691478	Map
OH	Rainbow Babies and Childrens Hospital	Cleveland44106	NCT05691478	Map
OH	Research Site	Cleveland44106	NCT07011719	Map
OH	Research Site	Cleveland44106	NCT05536141	Map
OH	Research Site	Cleveland44195	NCT05536141	Map
OH	University Hospitals Seidman Cancer Center	Cleveland44106	NCT05361720	Map
OH	Doctors Hospital	Columbus43228	NCT03866382	Map
OH	Grant Medical Center	Columbus43215	NCT03866382	Map
OH	Mount Carmel East Hospital	Columbus43213	NCT03866382	Map
OH	Mount Carmel Health Center West	Columbus43222	NCT03866382	Map
OH	Nationwide Children's Hospital	Columbus43205	NCT07194044	Map
OH	Nationwide Children's Hospital	Columbus43205	NCT05135975	Map
OH	Nationwide Children's Hospital	Columbus43205	NCT05691478	Map
OH	Ohio State University	Columbus43210	NCT06026410	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT03816345	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT05327686	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT05691478	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT06900595	Map
OH	Ohio State University Comprehensive Cancer Center	Columbus43210	NCT03866382	Map
OH	Riverside Methodist Hospital	Columbus43214	NCT03866382	Map
OH	The Mark H Zangmeister Center	Columbus43219	NCT03866382	Map
OH	The Ohio University	Columbus43210	NCT03899155	Map
OH	Dayton Children's Hospital	Dayton45404	NCT05691478	Map
OH	Miami Valley Hospital	Dayton45409	NCT05327686	Map
OH	Miami Valley Hospital North	Dayton45415	NCT05136196	Map
OH	Miami Valley Hospital North	Dayton45415	NCT05327686	Map
OH	Premier Blood and Cancer Center	Dayton45409	NCT05136196	Map
OH	Premier Blood and Cancer Center	Dayton45409	NCT05327686	Map
OH	Delaware Health Center-Grady Cancer Center	Delaware43015	NCT03866382	Map
OH	Grady Memorial Hospital	Delaware43015	NCT03866382	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005-1066	NCT05136196	Map
OH	Atrium Medical Center-Middletown Regional Hospital	Franklin45005-1066	NCT05327686	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT05136196	Map
OH	Miami Valley Cancer Care and Infusion	Greenville45331	NCT05327686	Map
OH	Kettering Medical Center	Kettering45429	NCT03866382	Map
OH	Fairfield Medical Center	Lancaster43130	NCT03866382	Map
OH	OhioHealth Mansfield Hospital	Mansfield44903	NCT03866382	Map
OH	Marietta Memorial Hospital	Marietta45750	NCT03866382	Map
OH	OhioHealth Marion General Hospital	Marion43302	NCT03866382	Map
OH	Memorial Hospital	Marysville43040	NCT03866382	Map
OH	UH Seidman Cancer Center at Lake Health Mentor Campus	Mentor44060	NCT05327686	Map
OH	Knox Community Hospital	Mount Vernon43050	NCT03866382	Map
OH	Licking Memorial Hospital	Newark43055	NCT03866382	Map
OH	University Hospitals Parma Medical Center	Parma44129	NCT05327686	Map
OH	Southern Ohio Medical Center	Portsmouth45662	NCT03866382	Map
OH	University Hospitals Portage Medical Center	Ravenna44266	NCT05327686	Map
OH	Springfield Regional Cancer Center	Springfield45504	NCT03866382	Map
OH	ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital	Toledo43606	NCT05691478	Map
OH	Upper Valley Medical Center	Troy45373	NCT05136196	Map
OH	Upper Valley Medical Center	Troy45373	NCT05327686	Map
OH	University of Cincinnati Cancer Center-West Chester	West Chester45069	NCT05327686	Map
OH	OhioHealth Westerville Medical Campus/Westerville Cancer Center	Westerville43082	NCT03866382	Map
OH	Saint Ann's Hospital	Westerville43081	NCT03866382	Map
OH	Genesis Healthcare System Cancer Care Center	Zanesville43701	NCT03866382	Map
OK	Cancer Centers of Southwest Oklahoma Research	Lawton73505	NCT06475989	Map
OK	Cancer Centers of Southwest Oklahoma Research	Lawton73505	NCT03866382	Map
OK	Mercy Hospital Oklahoma City	Oklahoma City73120	NCT06475989	Map
OK	OU Stephenson Cancer Center	Oklahoma City73104	NCT06026410	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT06475989	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05136196	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05327686	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT05691478	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT06900595	Map
OK	University of Oklahoma Health Sciences Center	Oklahoma City73104	NCT03866382	Map
OK	Oklahoma Cancer Specialists and Research Institute-Tulsa	Tulsa74146	NCT05327686	Map
OR	Saint Alphonsus Cancer Care Center-Baker City	Baker City97814	NCT06475989	Map
OR	Saint Charles Health System	Bend97701	NCT06475989	Map
OR	Saint Charles Health System	Bend97701	NCT05136196	Map
OR	Clackamas Radiation Oncology Center	Clackamas97015	NCT06475989	Map
OR	Clackamas Radiation Oncology Center	Clackamas97015	NCT05136196	Map
OR	Bay Area Hospital	Coos Bay97420	NCT06475989	Map
OR	Providence Hood River Memorial Hospital	Hood River97031	NCT06475989	Map
OR	Providence Newberg Medical Center	Newberg97132	NCT06475989	Map
OR	Providence Newberg Medical Center	Newberg97132	NCT05136196	Map
OR	Providence Newberg Medical Center	Newberg97132	NCT03866382	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT06475989	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT05136196	Map
OR	Saint Alphonsus Cancer Care Center-Ontario	Ontario97914	NCT03866382	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT06475989	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT05136196	Map
OR	Providence Willamette Falls Medical Center	Oregon City97045	NCT03866382	Map
OR	Legacy Emanuel Children's Hospital	Portland97227	NCT05691478	Map
OR	Oregon Health and Science University	Portland97239	NCT06475989	Map
OR	Oregon Health and Science University	Portland97239	NCT05691478	Map
OR	Oregon Health and Science University	Portland97239	NCT06811116	Map
OR	Oregon Health and Science University	Portland97239	NCT03866382	Map
OR	Providence Portland Medical Center	Portland97213	NCT06475989	Map
OR	Providence Portland Medical Center	Portland97213	NCT05136196	Map
OR	Providence Portland Medical Center	Portland97213	NCT03866382	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT06475989	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT05136196	Map
OR	Providence Saint Vincent Medical Center	Portland97225	NCT03866382	Map
OR	Research Site	Portland97212	NCT07011719	Map
OR	Saint Charles Health System-Redmond	Redmond97756	NCT06475989	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT06475989	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT05327686	Map
PA	Lehigh Valley Hospital-Cedar Crest	Allentown18103	NCT03866382	Map
PA	UPMC-Heritage Valley Health System Beaver	Beaver15009	NCT05327686	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT06475989	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT05327686	Map
PA	Lehigh Valley Hospital - Muhlenberg	Bethlehem18017	NCT03866382	Map
PA	Carlisle Regional Cancer Center	Carlisle17015	NCT05327686	Map
PA	Christiana Care Health System-Concord Health Center	Chadds Ford19317	NCT05327686	Map
PA	Geisinger Medical Center	Danville17822	NCT05327686	Map
PA	Geisinger Medical Center	Danville17822	NCT05691478	Map
PA	Pocono Medical Center	East Stroudsburg18301	NCT06475989	Map
PA	Pocono Medical Center	East Stroudsburg18301	NCT03866382	Map
PA	Saint Vincent Hospital	Erie16544	NCT05327686	Map
PA	UPMC Hillman Cancer Center Erie	Erie16505	NCT06475989	Map
PA	UPMC Hillman Cancer Center Erie	Erie16505	NCT05327686	Map
PA	UPMC Hillman Cancer Center Erie	Erie16505	NCT03866382	Map
PA	UPMC Cancer Center at UPMC Horizon	Farrell16121	NCT05327686	Map
PA	UPMC Cancer Centers - Arnold Palmer Pavilion	Greensburg15601	NCT05327686	Map
PA	UPMC Cancer Centers - Arnold Palmer Pavilion	Greensburg15601	NCT03866382	Map
PA	UPMC Pinnacle Cancer Center/Community Osteopathic Campus	Harrisburg17109	NCT05327686	Map
PA	Geisinger Medical Center-Cancer Center Hazleton	Hazleton18201	NCT05327686	Map
PA	Lehigh Valley Hospital-Hazleton	Hazleton18201	NCT06475989	Map
PA	Lehigh Valley Hospital-Hazleton	Hazleton18201	NCT03866382	Map
PA	Penn State Children's Hospital	Hershey17033	NCT05691478	Map
PA	Penn State Milton S Hershey Medical Center	Hershey17033-0850	NCT05327686	Map
PA	IRMC Cancer Center	Indiana15701	NCT05327686	Map
PA	Jefferson Hospital	Jefferson Hills15025	NCT05327686	Map
PA	Lancaster General Health	Lancaster17601	NCT03899155	Map
PA	Geisinger Medical Oncology-Lewisburg	Lewisburg17837	NCT05327686	Map
PA	UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion	Mechanicsburg17050	NCT05327686	Map
PA	Forbes Hospital	Monroeville15146	NCT05327686	Map
PA	Research Site	Monroeville15146	NCT07011719	Map
PA	UPMC Cancer Center - Monroeville	Monroeville15146	NCT05327686	Map
PA	UPMC Hillman Cancer Center - Monroeville	Monroeville15146	NCT05327686	Map
PA	UPMC Hillman Cancer Center - Monroeville	Monroeville15146	NCT03866382	Map
PA	Arnold Palmer Cancer Center Medical Oncology Norwin	N. Huntingdon15642	NCT03866382	—
PA	UPMC Hillman Cancer Center - New Castle	New Castle16105	NCT05327686	Map
PA	Children's Hospital of Philadelphia	Philadelphia19104	NCT05691478	Map
PA	Children's Hospital of Philadelphia	Philadelphia19104	NCT06156410	Map
PA	Fox Chase Cancer Center	Philadelphia19111	NCT05263050	Map
PA	Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100)	Philadelphia19104	NCT07405164	Map
PA	Saint Christopher's Hospital for Children	Philadelphia19134	NCT05691478	Map
PA	Thomas Jefferson University Hospital	Philadelphia19107	NCT05136196	Map
PA	Thomas Jefferson University Hospital	Philadelphia19107	NCT05691478	Map
PA	University of Pennsylvania	Philadelphia19104	NCT06156410	Map
PA	University of Pennsylvania/Abramson Cancer Center	Philadelphia19104	NCT06475989	Map
PA	Allegheny General Hospital	Pittsburgh15212	NCT05168163	Map
PA	Allegheny General Hospital	Pittsburgh15212	NCT05327686	Map
PA	Children's Hospital of Pittsburgh of UPMC	Pittsburgh15224	NCT05691478	Map
PA	Children's Hospital of Pittsburgh of UPMC	Pittsburgh15224	NCT06900595	Map
PA	Research Site	Pittsburgh15232	NCT05536141	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT06475989	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT03816345	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT05327686	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT05691478	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT06811116	Map
PA	University of Pittsburgh Cancer Institute (UPCI)	Pittsburgh15232	NCT03866382	Map
PA	UPMC Department of Urology	Pittsburgh15232	NCT05127824	Map
PA	UPMC Hillman Cancer Center	Pittsburgh15232	NCT06026410	Map
PA	UPMC Hillman Cancer Center	Pittsburgh15232	NCT03539822	Map
PA	UPMC-Magee Womens Hospital	Pittsburgh15213	NCT05327686	Map
PA	UPMC-Passavant Hospital	Pittsburgh15237	NCT05327686	Map
PA	UPMC-Passavant Hospital	Pittsburgh15237	NCT03866382	Map
PA	UPMC-Saint Clair Hospital Cancer Center	Pittsburgh15243	NCT05327686	Map
PA	UPMC-Saint Clair Hospital Cancer Center	Pittsburgh15243	NCT03866382	Map
PA	UPMC-Saint Margaret	Pittsburgh15215	NCT05327686	Map
PA	UPMC-Shadyside Hospital	Pittsburgh15232	NCT05327686	Map
PA	West Penn Hospital	Pittsburgh15224	NCT05327686	Map
PA	Geisinger Cancer Services-Pottsville	Pottsville17901	NCT05327686	Map
PA	Community Medical Center	Scranton18510	NCT05327686	Map
PA	UPMC Cancer Center at UPMC Northwest	Seneca16346	NCT05327686	Map
PA	UPMC Cancer Center-Washington	Washington15301	NCT05327686	Map
PA	UPMC Washington Hospital Radiation Oncology	Washington15301	NCT05327686	Map
PA	Reading Hospital	West Reading19611	NCT05327686	Map
PA	Wexford Health and Wellness Pavilion	Wexford15090	NCT05327686	Map
PA	Geisinger Wyoming Valley/Henry Cancer Center	Wilkes-Barre18711	NCT05327686	Map
PA	Divine Providence Hospital	Williamsport17754	NCT05327686	Map
PA	UPMC Memorial	York17408	NCT05327686	Map
RI	Smilow Cancer Hospital Care Center - Westerly	Westerly02891	NCT06475989	Map
SC	Prisma Health Cancer Institute - Spartanburg	Boiling Springs29316	NCT06900595	Map
SC	Medical University of South Carolina	Charleston29425	NCT06475989	Map
SC	Medical University of South Carolina	Charleston29425	NCT05327686	Map
SC	Medical University of South Carolina	Charleston29425	NCT05691478	Map
SC	Medical University of South Carolina	Charleston29425	NCT03866382	Map
SC	MUSC Hollings Cancer Center	Charleston29425	NCT07293351	Map
SC	Research Site	Charleston29425	NCT07011719	Map
SC	Prisma Health Richland Hospital	Columbia29203	NCT05691478	Map
SC	Prisma Health Richland Hospital	Columbia29203	NCT06900595	Map
SC	Prisma Health Cancer Institute - Easley	Easley29640	NCT06900595	Map
SC	BI-LO Charities Children's Cancer Center	Greenville29605	NCT05691478	Map
SC	BI-LO Charities Children's Cancer Center	Greenville29605	NCT06900595	Map
SC	Prisma Health Cancer Institute - Butternut	Greenville29605	NCT06900595	Map
SC	Prisma Health Cancer Institute - Eastside	Greenville29615	NCT06900595	Map
SC	Prisma Health Cancer Institute - Faris	Greenville29605	NCT06900595	Map
SC	Saint Francis Cancer Center	Greenville29607	NCT05691478	Map
SC	Saint Francis Hospital	Greenville29601	NCT05691478	Map
SC	Self Regional Healthcare	Greenwood29646	NCT05327686	Map
SC	Prisma Health Cancer Institute - Greer	Greer29650	NCT06900595	Map
SC	Carolina Urologic Research Center, LLC	Myrtle Beach29572	NCT07293351	Map
SC	Prisma Health Cancer Institute - Seneca	Seneca29672	NCT06900595	Map
SD	Rapid City Regional Hospital	Rapid City57701	NCT05136196	Map
SD	Rapid City Regional Hospital	Rapid City57701	NCT05168163	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT06475989	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT05136196	Map
SD	Sanford Cancer Center Oncology Clinic	Sioux Falls57104	NCT05327686	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT06475989	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05136196	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05327686	Map
SD	Sanford USD Medical Center - Sioux Falls	Sioux Falls57117-5134	NCT05691478	Map
TN	Baptist Memorial Hospital and Cancer Center-Collierville	Collierville38017	NCT07383441	Map
TN	East Tennessee Childrens Hospital	Knoxville37916	NCT05691478	Map
TN	Baptist Memorial Hospital and Cancer Center-Memphis	Memphis38120	NCT07383441	Map
TN	Saint Jude Children's Research Hospital	Memphis38105	NCT05691478	Map
TN	Saint Jude Children's Research Hospital	Memphis38105	NCT06900595	Map
TN	Research Site	Nashville37203	NCT07011719	Map
TN	Research Site	Nashville37232	NCT07011719	Map
TN	Research Site	Nashville37203	NCT05536141	Map
TN	Research Site	Nashville37240	NCT05536141	Map
TN	SCRI - Oncology Partners	Nashville37203	NCT06026410	Map
TN	SCRI Oncology Partners ( Site 7000)	Nashville37203	NCT07405164	Map
TN	Tennesse Oncology	Nashville37203	NCT03899155	Map
TN	The Children's Hospital at TriStar Centennial	Nashville37203	NCT05691478	Map
TN	Vanderbilt University Medical Center	Nashville37232	NCT05425004	Map
TN	Vanderbilt University Medical Center	Nashville37232	NCT07194044	Map
TN	Vanderbilt University/Ingram Cancer Center	Nashville37232	NCT06475989	Map
TN	Vanderbilt University/Ingram Cancer Center	Nashville37232	NCT05361720	Map
TN	Vanderbilt University/Ingram Cancer Center	Nashville37232	NCT05691478	Map
TN	Vanderbilt University/Ingram Cancer Center	Nashville37232	NCT03866382	Map
TX	Dell Children's Medical Center of Central Texas	Austin78723	NCT05691478	Map
TX	Dell Children's Medical Center of Central Texas	Austin78723	NCT06900595	Map
TX	Driscoll Children's Hospital	Corpus Christi78411	NCT05691478	Map
TX	Medical City Dallas Hospital	Dallas75230	NCT05691478	Map
TX	Parkland Memorial Hospital	Dallas75235	NCT05327686	Map
TX	Research Site	Dallas75390	NCT07011719	Map
TX	University of Texas, Southwestern Medical Center	Dallas75390	NCT05361720	Map
TX	UT Southwestern	Dallas75390	NCT05797805	Map
TX	UT Southwestern Medical Center	Dallas75390	NCT05931393	Map
TX	UT Southwestern Simmons Cancer Center	Dallas75235	NCT06026410	Map
TX	UT Southwestern Simmons Cancer Center - RedBird	Dallas75237	NCT03816345	Map
TX	UT Southwestern Simmons Cancer Center - RedBird	Dallas75237	NCT05327686	Map
TX	UT Southwestern Simmons Cancer Center - RedBird	Dallas75237	NCT03866382	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT03816345	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT05327686	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT05691478	Map
TX	UT Southwestern/Simmons Cancer Center-Dallas	Dallas75390	NCT03866382	Map
TX	El Paso Children's Hospital	El Paso79905	NCT05691478	Map
TX	Cook Children's Medical Center	Fort Worth76104	NCT05691478	Map
TX	UT Southwestern/Simmons Cancer Center-Fort Worth	Fort Worth76104	NCT03816345	Map
TX	UT Southwestern/Simmons Cancer Center-Fort Worth	Fort Worth76104	NCT05327686	Map
TX	UT Southwestern/Simmons Cancer Center-Fort Worth	Fort Worth76104	NCT03866382	Map
TX	Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center	Houston77030	NCT05691478	Map
TX	M D Anderson Cancer Center	Houston77030	NCT05092373	Map
TX	M D Anderson Cancer Center	Houston77030	NCT05048212	Map
TX	M D Anderson Cancer Center	Houston77030	NCT05019703	Map
TX	MD Anderson Cancer Center	Houston77030	NCT05797805	Map
TX	MD Anderson Cancer Center	Houston77030	NCT05663710	Map
TX	MD Anderson Cancer Center	Houston77030	NCT06026410	Map
TX	UT MD Anderson Cancer Center	Houston77030	NCT03816345	Map
TX	UT MD Anderson Cancer Center	Houston77030	NCT05691478	Map
TX	Covenant Children's Hospital	Lubbock79410	NCT05691478	Map
TX	Research Site	Lubbock79430	NCT07011719	Map
TX	UMC Cancer Center / UMC Health System	Lubbock79415	NCT05691478	Map
TX	UT Southwestern Clinical Center at Richardson/Plano	Richardson75080	NCT03816345	Map
TX	UT Southwestern Clinical Center at Richardson/Plano	Richardson75080	NCT05327686	Map
TX	UT Southwestern Clinical Center at Richardson/Plano	Richardson75080	NCT03866382	Map
TX	Children's Hospital of San Antonio	San Antonio78207	NCT05691478	Map
TX	Children's Hospital of San Antonio	San Antonio78207	NCT06900595	Map
TX	Methodist Children's Hospital of South Texas	San Antonio78229	NCT05691478	Map
TX	Research Site	San Antonio78229	NCT05536141	Map
TX	START San Antonio ( Site 0104)	San Antonio78229	NCT07405164	Map
TX	University of Texas Health Science Center at San Antonio	San Antonio78229	NCT05691478	Map
TX	University of Texas Health Science Center at San Antonio	San Antonio78229	NCT06900595	Map
TX	Scott and White Memorial Hospital	Temple76508	NCT05327686	Map
TX	Scott and White Memorial Hospital	Temple76508	NCT05691478	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT06475989	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT05773274	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT05168618	Map
UT	Huntsman Cancer Institute/University of Utah	Salt Lake City84112	NCT05136196	Map
UT	Primary Children's Hospital	Salt Lake City84113	NCT07194044	Map
UT	Primary Children's Hospital	Salt Lake City84113	NCT05135975	Map
UT	Primary Children's Hospital	Salt Lake City84113	NCT05691478	Map
UT	Research Site	Salt Lake City84112	NCT07011719	Map
VT	Central Vermont Medical Center/National Life Cancer Treatment	Berlin Corners05602	NCT05327686	Map
VT	University of Vermont and State Agricultural College	Burlington05405	NCT05327686	Map
VT	University of Vermont Medical Center	Burlington05401	NCT05327686	Map
VT	Dartmouth Cancer Center - North	Saint Johnsbury05819	NCT05136196	Map
VA	Inova Alexandria Hospital	Alexandria22304	NCT05136196	Map
VA	Inova Alexandria Hospital	Alexandria22304	NCT05327686	Map
VA	Research Site	Charlottesville22903	NCT07011719	Map
VA	University of Virginia Cancer Center	Charlottesville22908	NCT05691478	Map
VA	Inova Fair Oaks Hospital	Fairfax22033	NCT05136196	Map
VA	Inova Fair Oaks Hospital	Fairfax22033	NCT05327686	Map
VA	Inova Schar Cancer Institute	Fairfax22031	NCT05136196	Map
VA	Inova Schar Cancer Institute	Fairfax22031	NCT05327686	Map
VA	Inova Fairfax Hospital	Falls Church22042	NCT05136196	Map
VA	Centra Alan B Pearson Regional Cancer Center	Lynchburg24501	NCT05136196	Map
VA	Bon Secours Saint Francis Medical Center	Midlothian23114	NCT05327686	Map
VA	Children's Hospital of The King's Daughters	Norfolk23507	NCT05691478	Map
VA	Bon Secours Cancer Institute at Reynolds Crossing	Richmond23230	NCT05327686	Map
VA	VCU Massey Cancer Center at Stony Point	Richmond23235	NCT05136196	Map
VA	VCU Massey Cancer Center at Stony Point	Richmond23235	NCT05691478	Map
VA	VCU Massey Cancer Center at Stony Point	Richmond23235	NCT06900595	Map
VA	VCU Massey Comprehensive Cancer Center	Richmond23298	NCT03816345	Map
VA	VCU Massey Comprehensive Cancer Center	Richmond23298	NCT05136196	Map
VA	VCU Massey Comprehensive Cancer Center	Richmond23298	NCT05691478	Map
VA	VCU Massey Comprehensive Cancer Center	Richmond23298	NCT06900595	Map
VA	Virginia Cancer Institute	Richmond23229	NCT05136196	Map
VA	VCU Health Tappahannock Hospital	Tappahannock22560	NCT05136196	Map
WA	Providence Regional Cancer System-Aberdeen	Aberdeen98520	NCT06475989	Map
WA	PeaceHealth Saint Joseph Medical Center	Bellingham98225	NCT06475989	Map
WA	Providence Regional Cancer System-Centralia	Centralia98531	NCT06475989	Map
WA	Swedish Cancer Institute-Edmonds	Edmonds98026	NCT06475989	Map
WA	Providence Regional Cancer Partnership	Everett98201	NCT06475989	Map
WA	Swedish Cancer Institute-Issaquah	Issaquah98029	NCT06475989	Map
WA	Kadlec Clinic Hematology and Oncology	Kennewick99336	NCT06475989	Map
WA	Kadlec Clinic Hematology and Oncology	Kennewick99336	NCT03866382	Map
WA	Providence Regional Cancer System-Lacey	Lacey98503	NCT06475989	Map
WA	PeaceHealth Saint John Medical Center	Longview98632	NCT06475989	Map
WA	Skagit Regional Health Cancer Care Center	Mount Vernon98274	NCT06475989	Map
WA	Valley Medical Center	Renton98055	NCT03866382	Map
WA	Fred Hutchinson Cancer Center	Seattle98133	NCT05797805	Map
WA	Fred Hutchinson Cancer Center	Seattle98109	NCT06900595	Map
WA	Fred Hutchinson Cancer Center ( Site 0106)	Seattle98109	NCT07405164	Map
WA	Research Site	Seattle98109	NCT07011719	Map
WA	Seattle Children's Hospital	Seattle98105	NCT05691478	Map
WA	Swedish Medical Center-Ballard Campus	Seattle98107	NCT06475989	Map
WA	Swedish Medical Center-Cherry Hill	Seattle98122-5711	NCT06475989	Map
WA	Swedish Medical Center-First Hill	Seattle98122	NCT06475989	Map
WA	Virginia Mason Medical Center	Seattle98101	NCT05327686	Map
WA	PeaceHealth United General Medical Center	Sedro-Woolley98284	NCT06475989	Map
WA	Cancer Care Northwest - Spokane South	Spokane99202	NCT06475989	Map
WA	Cancer Care Northwest-North Spokane	Spokane99218	NCT06475989	Map
WA	Cancer Care Northwest-Valley	Spokane99216	NCT06475989	Map
WA	Providence Sacred Heart Medical Center and Children's Hospital	Spokane99204	NCT05691478	Map
WA	Madigan Army Medical Center	Tacoma98431	NCT05691478	Map
WA	Mary Bridge Children's Hospital and Health Center	Tacoma98405	NCT05691478	Map
WA	PeaceHealth Southwest Medical Center	Vancouver98664	NCT06475989	Map
WA	Providence Saint Mary Regional Cancer Center	Walla Walla99362	NCT06475989	Map
WV	West Virginia University Charleston Division	Charleston25304	NCT05691478	Map
WV	Edwards Comprehensive Cancer Center	Huntington25701	NCT05327686	Map
WI	Langlade Hospital and Cancer Center	Antigo54409	NCT05327686	Map
WI	Duluth Clinic Ashland	Ashland54806	NCT05136196	Map
WI	Duluth Clinic Ashland	Ashland54806	NCT05327686	Map
WI	Duluth Clinic Ashland	Ashland54806	NCT03866382	Map
WI	Northwest Wisconsin Cancer Center	Ashland54806	NCT05327686	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT06475989	Map
WI	Aurora Cancer Care-Southern Lakes VLCC	Burlington53105	NCT03866382	Map
WI	Aurora Saint Luke's South Shore	Cudahy53110	NCT06475989	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT06475989	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT05136196	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT05327686	Map
WI	Marshfield Medical Center-EC Cancer Center	Eau Claire54701	NCT03866382	Map
WI	Mayo Clinic Health System-Eau Claire Clinic	Eau Claire54701	NCT03866382	Map
WI	Aurora Health Care Germantown Health Center	Germantown53022	NCT06475989	Map
WI	Aurora Health Care Germantown Health Center	Germantown53022	NCT03866382	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT06475989	Map
WI	Aurora Cancer Care-Grafton	Grafton53024	NCT03866382	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT06475989	Map
WI	Aurora BayCare Medical Center	Green Bay54311	NCT03866382	Map
WI	Saint Vincent Hospital Cancer Center at Saint Mary's	Green Bay54303	NCT05136196	Map
WI	Saint Vincent Hospital Cancer Center at Saint Mary's	Green Bay54303	NCT05327686	Map
WI	Saint Vincent Hospital Cancer Center Green Bay	Green Bay54301	NCT05136196	Map
WI	Saint Vincent Hospital Cancer Center Green Bay	Green Bay54301	NCT05327686	Map
WI	Saint Vincent Hospital Cancer Center Green Bay	Green Bay54301	NCT05691478	Map
WI	Essentia Health-Hayward Clinic	Hayward54843	NCT05327686	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT06475989	Map
WI	Aurora Cancer Care-Kenosha South	Kenosha53142	NCT03866382	Map
WI	Gundersen Lutheran Medical Center	La Crosse54601	NCT05136196	Map
WI	Gundersen Lutheran Medical Center	La Crosse54601	NCT05327686	Map
WI	University of Wisconsin (Carbone Cancer Center)	Madison53792	NCT06026410	Map
WI	University of Wisconsin Carbone Cancer Center - Eastpark Medical Center	Madison53718	NCT05327686	Map
WI	University of Wisconsin Carbone Cancer Center - University Hospital	Madison53792	NCT05327686	Map
WI	University of Wisconsin Carbone Cancer Center - University Hospital	Madison53792	NCT05691478	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT06475989	Map
WI	Aurora Bay Area Medical Group-Marinette	Marinette54143	NCT03866382	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT06475989	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05136196	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05327686	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT05691478	Map
WI	Marshfield Medical Center-Marshfield	Marshfield54449	NCT03866382	Map
WI	Froedtert Menomonee Falls Hospital	Menomonee Falls53051	NCT05327686	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT06475989	Map
WI	Aurora Cancer Care-Milwaukee	Milwaukee53209	NCT03866382	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT06475989	Map
WI	Aurora Saint Luke's Medical Center	Milwaukee53215	NCT03866382	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT06475989	Map
WI	Aurora Sinai Medical Center	Milwaukee53233	NCT03866382	Map
WI	Children's Hospital of Wisconsin	Milwaukee53226	NCT05691478	Map
WI	Froedtert and the Medical College of Wisconsin LAPS	Milwaukee53226	NCT05168163	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT05136196	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT05168163	Map
WI	Medical College of Wisconsin	Milwaukee53226	NCT05327686	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT06475989	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT05136196	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT05327686	Map
WI	Marshfield Medical Center - Minocqua	Minocqua54548	NCT03866382	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT05136196	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT05327686	Map
WI	ProHealth D N Greenwald Center	Mukwonago53149	NCT03866382	Map
WI	Cancer Center of Western Wisconsin	New Richmond54017	NCT06475989	Map
WI	Cancer Center of Western Wisconsin	New Richmond54017	NCT05136196	Map
WI	Cancer Center of Western Wisconsin	New Richmond54017	NCT05327686	Map
WI	Drexel Town Square Health Center	Oak Creek53154	NCT05327686	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT05136196	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT05327686	Map
WI	ProHealth Oconomowoc Memorial Hospital	Oconomowoc53066	NCT03866382	Map
WI	Saint Vincent Hospital Cancer Center at Oconto Falls	Oconto Falls54154	NCT05136196	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT06475989	Map
WI	Vince Lombardi Cancer Clinic - Oshkosh	Oshkosh54904	NCT03866382	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT06475989	Map
WI	Aurora Cancer Care-Racine	Racine53406	NCT03866382	Map
WI	Aspirus Cancer Care - James Beck Cancer Center	Rhinelander54501	NCT05327686	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT06475989	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT05136196	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT05327686	Map
WI	Marshfield Medical Center-Rice Lake	Rice Lake54868	NCT03866382	Map
WI	Saint Vincent Hospital Cancer Center at Sheboygan	Sheboygan53081	NCT05136196	Map
WI	Saint Vincent Hospital Cancer Center at Sheboygan	Sheboygan53081	NCT05327686	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT06475989	Map
WI	Vince Lombardi Cancer Clinic-Sheboygan	Sheboygan53081	NCT03866382	Map
WI	Essentia Health-Spooner Clinic	Spooner54801	NCT05327686	Map
WI	Aspirus Cancer Care - Stevens Point	Stevens Point54481	NCT05327686	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT06475989	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT05136196	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT05327686	Map
WI	Marshfield Medical Center-River Region at Stevens Point	Stevens Point54482	NCT03866382	Map
WI	Saint Vincent Hospital Cancer Center at Sturgeon Bay	Sturgeon Bay54235-1495	NCT05136196	Map
WI	Saint Vincent Hospital Cancer Center at Sturgeon Bay	Sturgeon Bay54235-1495	NCT05327686	Map
WI	Aurora Medical Center in Summit	Summit53066	NCT06475989	—
WI	Aurora Medical Center in Summit	Summit53066	NCT03866382	—
WI	Essentia Health Saint Mary's Hospital - Superior	Superior54880	NCT05136196	Map
WI	Essentia Health Saint Mary's Hospital - Superior	Superior54880	NCT05327686	Map
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT06475989	Map
WI	Vince Lombardi Cancer Clinic-Two Rivers	Two Rivers54241	NCT03866382	Map
WI	ProHealth Waukesha Memorial Hospital	Waukesha53188	NCT05136196	Map
WI	ProHealth Waukesha Memorial Hospital	Waukesha53188	NCT03866382	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT05136196	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT05327686	Map
WI	UW Cancer Center at ProHealth Care	Waukesha53188	NCT03866382	Map
WI	Aspirus Regional Cancer Center	Wausau54401	NCT05327686	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT06475989	Map
WI	Aurora Cancer Care-Milwaukee West	Wauwatosa53226	NCT03866382	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT06475989	Map
WI	Aurora West Allis Medical Center	West Allis53227	NCT03866382	Map
WI	Froedtert West Bend Hospital/Kraemer Cancer Center	West Bend53095	NCT05327686	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT06475989	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT05136196	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT05327686	Map
WI	Marshfield Medical Center - Weston	Weston54476	NCT03866382	Map
WI	Aspirus Cancer Care - Wisconsin Rapids	Wisconsin Rapids54494	NCT05327686	Map
WY	Memorial Hospital of Laramie County	Cheyenne82001	NCT06475989	Map
WY	Billings Clinic-Cody	Cody82414	NCT06475989	Map

Cabozantinib clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	completed	terminated	withdrawn	suspended	not yet recruiting	unknown	approved for marketing	Total
Early P1	1									1
P1	7	7	21	3		1	2			41
P1/P2	7	1	5	6	1					20
P2	28	32	49	18	3	1	4	12		147
P2/P3	1									1
P3	7	11	4	3	1					26
P4	2	1	1				1			5
N/A	1		8						1	10

Recruiting Cabozantinib clinical trials (61)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT06502171	NF113Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas	P1	Neurofibromatosis 1	30	Aug 2026
NCT07383441	Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer	P3	Advanced Clear Cell Renal Cell Carcinoma	718	Jun 2026
NCT07405164	Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)	P3	Von Hippel-Lindau Disease	450	Mar 2026
NCT06726421	STROKERSystemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)	P3	Renal Cell Carcinoma (Kidney Cancer)	252	Sep 2024
NCT06364631	CARE1CARE1 Pragmatic Clinical Trial	P3	Metastatic Kidney Cancer	1,250	Apr 2024
NCT07227402	LITESPARK-033A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)	P3	Renal Cell Carcinoma	904	Nov 2025
NCT07293351	RCCA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)	P1/P2	Advanced Renal Cell Carcinoma (RCC)	254	Mar 2026
NCT07011719	Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma	P3	Metastatic Clear Cell Renal Cell Carcinoma	720	Sep 2025
NCT07194044	METTSEOMetastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes	P1	Metastatic Ewing Sarcoma	15	Feb 2026
NCT06475989	Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer	P3	Refractory Differentiated Thyroid Gland Carcinoma	264	Aug 2024
NCT05691478	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	P2/P3	High Grade Osteosarcoma	1,122	Mar 2023
NCT05135975	A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors	P2	Neuroblastoma	86	Jul 2022
NCT03899155	Pan Tumor Rollover Study	P2	Cancer	1,500	Aug 2019
NCT03539822	CAMILLACabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies	P1/P2	Gastric Cancer	117	Oct 2018
NCT06900595	REGN2810Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer	P2	Locally Advanced Adrenal Cortical Carcinoma	48	Feb 2026
NCT05773274	Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial	P2	Metastatic Digestive System Neuroendocrine Tumor G1	100	Jan 2024
NCT07187869	Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study	P1	Clear Cell Renal Cell Carcinoma	16	Mar 2026
NCT05536141	ARC-20A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors	P1	Clear Cell Renal Cell Carcinoma	362	Oct 2022
NCT07028125	CANIQOLDigital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma	P4	Renal Cell Carcinoma (Kidney Cancer)	83	Oct 2025
NCT07010393	Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study	P4	Thyroid Neoplasms	335	Jul 2025
NCT05931393	RCCSequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)	P2	RCC	18	Dec 2023
NCT04878029	Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer	P1	Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation	32	Jul 2021
NCT06006013	Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer	P2	Locally Advanced Adrenal Cortex Carcinoma	21	Jan 2025
NCT06156410	Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas	P1	Ewing Sarcoma	30	Oct 2023
NCT05613413	LUNG-IST-127A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)	P2	Metastatic Squamous Non-Small Cell Lung Carcinoma	36	Dec 2022
NCT07077161	SKIPPY 2Cabozantinib Dose Skipping as an Alternative to Dose Reductions	P2	Renal Cell Carcinoma (RCC)	34	Jan 2026
NCT07151326	CAPIOCabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy	P2	Hepatocellular Carcinoma (HCC)	60	Sep 2025
NCT05859217	Cabatezo-1A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)	P2	Lung Cancer	40	Dec 2024
NCT05327686	SAMURAITesting the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial	P2	Metastatic Renal Cell Carcinoma	240	Feb 2023
NCT05425004	Cabozantinib for Patients With Recurrent or Progressive Meningioma	P2	Meningioma	24	Jun 2022
NCT06934057	CABOLDCabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma	P4	Kidney Cancer	50	May 2025
NCT03816345	Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	P1	Autoimmune Disease	300	Jul 2019
NCT05127824	Autologous Dendritic Cell Vaccine in Kidney Cancer	P2	Carcinoma, Renal Cell	42	Jul 2023
NCT05019703	Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study	P2	Locally Advanced Osteosarcoma	40	Apr 2023
NCT05048212	A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases	P2	Brain Metastases	20	Sep 2022
NCT05182164	PEMBROCABOSARCCombination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas	P2	Soft Tissue Sarcoma Adult	119	Apr 2022
NCT05048901	Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors	P1/P2	Neuroendocrine Tumors,Gastroenteropancreatic	49	Sep 2021
NCT02925234	DRUPThe Drug Rediscovery Protocol (DRUP Trial)	P2	Cancer	1,550	Aug 2016
NCT04116541	MegaMOSTA Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.	P2	Malignant Solid Tumor	455	Jan 2020
NCT05663710	Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC	P1/P2	Advanced Cancer	100	Jun 2023
NCT04472767	Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma	P2	Hepatocellular Carcinoma	35	Aug 2020
NCT06811116	Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial	P1/P2	Advanced Hepatocellular Carcinoma	92	Nov 2025
NCT05361720	Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study	P2	Advanced Clear Cell Renal Cell Carcinoma	54	Dec 2022
NCT06026410	FIT-001KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors	P1	Solid Tumors With HRAS Alterations	300	Oct 2023
NCT05241561	Cabo-POLARISCabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients	P2	Cancer of Kidney	24	Jun 2022
NCT06835972	A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)	P1/P2	Metastatic Renal Cell Carcinoma	43	Feb 2025
NCT05263050	Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors	P2	Metastatic Renal Cell Carcinoma	111	Jan 2022
NCT03866382	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	P2	Bladder Adenocarcinoma	314	May 2019
NCT05168618	AtezoCabCabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer	P2	Castration-Resistant Prostate Carcinoma	33	Mar 2022
NCT05136196	BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study	P2	Clinical Stage III Cutaneous Melanoma AJCC v8	150	Dec 2022
NCT06535737	CPABA Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab	P2	Hepatocellular Carcinoma Non-resectable	40	Aug 2024
NCT05188118	Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma	Early P1	Renal Cell Carcinoma	20	Feb 2023
NCT05168163	Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	P2	Locally Advanced Hepatocellular Carcinoma	122	May 2022
NCT04893785	CABOTEMA Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)	P2	Lung Neuroendocrine Neoplasm	35	Jun 2021
NCT05092373	TTFPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax	P1	Advanced Breast Carcinoma	43	Apr 2022
NCT01639508	Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity	P2	Non-Small Cell Lung Cancer	86	Jul 2012
NCT05797805	BC2059A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma	P1/P2	Advanced Hepatocellular Carcinoma	178	Sep 2023
NCT04204850	Cabozantinib to Treat Recurrent Liver Cancer Post Transplant	P2	Hepatocellular Carcinoma	20	Aug 2020
NCT03899428	Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC	P2	Hepatocellular Carcinoma	30	May 2019
NCT06482086	Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer	P2	Locally Advanced Thyroid Gland Carcinoma	75	Jun 2021
NCT06548867	CABOGENRetrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib	—	Metastatic Renal Cell Carcinoma	80	May 2024

Cabozantinib clinical trials by indication

Renal Cell Carcinoma (13)

NCT	Acronym	Phase	Status	Title
NCT07227402	LITESPARK-033	P3	recruiting	A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
NCT03937219	COSMIC-313	P3	active not recruiting	Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
NCT05188118	—	Early P1	recruiting	Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
NCT03141177	CheckMate 9ER	P3	active not recruiting	A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
NCT03685448	UNICAB	P2	completed	ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
NCT04804813	—	N/A	completed	Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
NCT04540705	PIVOT IO 011	P1	completed	A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread
NCT04416646	ZEBRA	N/A	completed	Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
+ 5 more, see All trials below.

Hepatocellular Carcinoma (11)

NCT	Acronym	Phase	Status	Title
NCT04472767	—	P2	recruiting	Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
NCT03755791	COSMIC-312	P3	active not recruiting	Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
NCT04204850	—	P2	recruiting	Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
NCT03899428	—	P2	recruiting	Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
NCT01658878	CheckMate040	P1/P2	completed	An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer
NCT04767906	CaPture	P2	completed	Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
NCT04454762	CaboCHILD	P2	unknown	A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function
NCT05039736	TKI	P2	withdrawn	A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
+ 3 more, see All trials below.

Prostate Cancer (8)

NCT	Acronym	Phase	Status	Title
NCT04631744	—	P2	terminated	Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
NCT01574937	—	P1	completed	XL-184+Abiraterone in Post-Chemo CRPC
NCT03964337	SPARC	P2	terminated	Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer
NCT01630590	—	P2	completed	Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
NCT01834651	XL184	P2	completed	A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases
NCT01605227	COMET-1	P3	completed	Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
NCT01522443	COMET-2	P3	terminated	Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
NCT01995058	—	P2	terminated	Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

Metastatic Renal Cell Carcinoma (7)

NCT	Acronym	Phase	Status	Title
NCT05327686	SAMURAI	P2	recruiting	Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
NCT06132945	—	P1	active not recruiting	A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
NCT06835972	—	P1/P2	recruiting	A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
NCT05263050	—	P2	recruiting	Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
NCT06548867	CABOGEN	N/A	recruiting	Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
NCT03967522	CABRAMET	P2	completed	Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases
NCT03149822	—	P1/P2	completed	Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma (6)

NCT	Acronym	Phase	Status	Title
NCT07187869	—	P1	not yet recruiting	Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
NCT05536141	ARC-20	P1	recruiting	A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
NCT03793166	—	P3	active not recruiting	Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
NCT04022343	—	P2	active not recruiting	Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
NCT04300140	—	P1/P2	terminated	Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
NCT01835158	—	P2	completed	Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Advanced Clear Cell Renal Cell Carcinoma (4)

NCT	Acronym	Phase	Status	Title
NCT07383441	—	P3	recruiting	Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
NCT05012371	—	P2	active not recruiting	Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
NCT05361720	—	P2	recruiting	Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
NCT05122546	—	P1	active not recruiting	CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Advanced Hepatocellular Carcinoma (4)

NCT	Acronym	Phase	Status	Title
NCT06811116	—	P1/P2	recruiting	Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
NCT05797805	BC2059	P1/P2	recruiting	A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
NCT04442581	—	P2	terminated	Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
NCT03586973	—	P2	completed	A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma

Medullary Thyroid Cancer (4)

NCT	Acronym	Phase	Status	Title
NCT04760288	AcceleRET-MTC	P3	withdrawn	A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).
NCT01896479	EXAMINER	P4	active not recruiting	A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
NCT04211337	LIBRETTO-531	P3	active not recruiting	A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
NCT01683110	—	N/A	approved for marketing	Expanded Access of Cabozantinib in Medullary Thyroid Cancer

Cancer (4)

NCT	Acronym	Phase	Status	Title
NCT03899155	—	P2	recruiting	Pan Tumor Rollover Study
NCT03768063	IMbrella B	P3	active not recruiting	A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
NCT02925234	DRUP	P2	recruiting	The Drug Rediscovery Protocol (DRUP Trial)
NCT05289856	NEN G3	P2	unknown	Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Colorectal Cancer (4)

NCT	Acronym	Phase	Status	Title
NCT03798626	—	P1	completed	Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
NCT04868773	—	P1	completed	Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
NCT03542877	—	P2	completed	Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer
NCT02008383	CaboMAb	P1	completed	Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer

Breast Cancer (4)

NCT	Acronym	Phase	Status	Title
NCT02260531	—	P2	completed	Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
NCT03316586	—	P2	completed	A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
NCT01441947	—	P2	completed	Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
NCT01738438	—	P2	completed	Cabozantinib for Metastatic Triple Negative BrCa

Carcinoma, Renal Cell (3)

NCT	Acronym	Phase	Status	Title
NCT05127824	—	P2	recruiting	Autologous Dendritic Cell Vaccine in Kidney Cancer
NCT04586231	MK-6482	P3	active not recruiting	A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
NCT04338269	CONTACT-03	P3	terminated	A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

Pancreatic Cancer (3)

NCT	Acronym	Phase	Status	Title
NCT04820179	—	P2	active not recruiting	Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
NCT05052723	—	P2	completed	Cabozantinib and Pembrolizumab in Metastatic Pancreas
NCT01663272	XL184	P1	completed	A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

Advanced Renal Cell Carcinoma (3)

NCT	Acronym	Phase	Status	Title
NCT04071223	—	P2	active not recruiting	Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT03428217	CANTATA	P2	completed	CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
NCT03339219	—	P2	completed	A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

Urothelial Carcinoma (3)

NCT	Acronym	Phase	Status	Title
NCT03170960	—	P1	active not recruiting	Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT04066595	CabUC	P2	terminated	Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
NCT01688999	—	P2	completed	Cabozantinib for Advanced Urothelial Cancer

Metastatic Ewing Sarcoma (2)

NCT	Acronym	Phase	Status	Title
NCT07194044	METTSEO	P1	recruiting	Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
NCT02243605	—	P2	active not recruiting	Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Renal Cell Carcinoma (RCC) (2)

NCT	Acronym	Phase	Status	Title
NCT07077161	SKIPPY 2	P2	recruiting	Cabozantinib Dose Skipping as an Alternative to Dose Reductions
NCT03634540	MK-6482-003	P2	active not recruiting	A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Renal Cell Carcinoma (Kidney Cancer) (2)

NCT	Acronym	Phase	Status	Title
NCT06726421	STROKER	P3	recruiting	Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
NCT07028125	CANIQOL	P4	recruiting	Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

Hepatocellular Carcinoma (HCC) (2)

NCT	Acronym	Phase	Status	Title
NCT07151326	CAPIO	P2	not yet recruiting	Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
NCT04522908	—	P2	completed	Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Kidney Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT06934057	CABOLD	P4	recruiting	Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
NCT04322955	Cyto-KIK	P2	active not recruiting	CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT05859217	Cabatezo-1	P2	not yet recruiting	A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
NCT01588821	—	P2	completed	Cabozantinib in Advanced Solid Malignancies

Hepatocellular Carcinoma Non-resectable (2)

NCT	Acronym	Phase	Status	Title
NCT06535737	CPAB	P2	not yet recruiting	A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab
NCT04511455	HCC	P2	completed	Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

Differentiated Thyroid Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT03690388	VEGFR	P3	active not recruiting	A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
NCT05660954	CABOTHYROID	P2	completed	Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.

Neuroendocrine Tumors (2)

NCT	Acronym	Phase	Status	Title
NCT05249114	—	P1	active not recruiting	Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
NCT04524208	CABONEN	P2	active not recruiting	A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

Locally Advanced Hepatocellular Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT05168163	—	P2	recruiting	Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
NCT03299946	HCC	P1	completed	Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)

Advanced Malignant Solid Neoplasm (2)

NCT	Acronym	Phase	Status	Title
NCT05038839	—	P1	completed	Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
NCT01822522	—	P1	completed	Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT04310007	—	P2	active not recruiting	Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
NCT03468985	—	P2	completed	Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Differentiated Thyroid Gland Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT03914300	—	P2	active not recruiting	Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
NCT02592356	—	N/A	completed	Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Locally Advanced or Metastatic Renal Cell Carcinoma (2)

NCT	Acronym	Phase	Status	Title
NCT03945773	CaboPoint	P2	completed	Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
NCT04353765	US NIS Cabo	N/A	completed	Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors

Non Small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT04131543	CRETA	P2	unknown	Phase II Study With Cabozantinib in Patients With RET Positive NSCLC
NCT04173338	—	P1	terminated	Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Carcinoid Tumor (2)

NCT	Acronym	Phase	Status	Title
NCT04197310	—	P2	completed	Cabozantinib and Nivolumab for Carcinoid Tumors
NCT01466036	—	P2	completed	Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Non-Small Cell Lung Cancer (2)

NCT	Acronym	Phase	Status	Title
NCT01639508	—	P2	recruiting	Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
NCT03911193	CABinMET	P2	unknown	CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation

Multiple Myeloma (2)

NCT	Acronym	Phase	Status	Title
NCT03201250	—	P1/P2	terminated	Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
NCT01582295	MM	P1	completed	XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Adenocarcinoma of the Prostate (2)

NCT	Acronym	Phase	Status	Title
NCT01812668	—	N/A	completed	Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
NCT01703065	—	P2	terminated	Cabozantinib in Men With Castration-Resistant Prostate Cancer

Healthy (2)

NCT	Acronym	Phase	Status	Title
NCT01493869	XL184	P1	completed	Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
NCT01761773	XL184	P1	completed	A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Solid Tumors (2)

NCT	Acronym	Phase	Status	Title
NCT01553656	XL184	P1	completed	Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer
NCT00940225	XL184	P2	completed	Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Neurofibromatosis 1 (1)

NCT	Acronym	Phase	Status	Title
NCT06502171	NF113	P1	not yet recruiting	Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Advanced Renal Cell Carcinoma (RCC) (1)

NCT	Acronym	Phase	Status	Title
NCT07293351	RCC	P1/P2	recruiting	A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Von Hippel-Lindau Disease (1)

NCT	Acronym	Phase	Status	Title
NCT07405164	—	P3	recruiting	Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Locally Advanced Adrenal Cortical Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06900595	REGN2810	P2	recruiting	Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Metastatic Clear Cell Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT07011719	—	P3	recruiting	Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Thyroid Neoplasms (1)

NCT	Acronym	Phase	Status	Title
NCT07010393	—	P4	not yet recruiting	Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Locally Advanced Adrenal Cortex Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06006013	—	P2	recruiting	Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Osteosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT06341712	CabOSTar	P2	terminated	Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma

Clear Cell RCC (1)

NCT	Acronym	Phase	Status	Title
NCT06716853	TEM-GU	P1/P2	terminated	A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Refractory Differentiated Thyroid Gland Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06475989	—	P3	recruiting	Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Metastatic Kidney Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT06364631	CARE1	P3	recruiting	CARE1 Pragmatic Clinical Trial

Metastatic Nasopharyngeal Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05904080	—	P2	suspended	Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Metastatic Digestive System Neuroendocrine Tumor G1 (1)

NCT	Acronym	Phase	Status	Title
NCT05773274	—	P2	recruiting	Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

RCC (1)

NCT	Acronym	Phase	Status	Title
NCT05931393	RCC	P2	recruiting	Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

Locally Advanced Extraskeletal Myxoid Chondrosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT05836571	—	P2	active not recruiting	Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Ewing Sarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT06156410	—	P1	recruiting	Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Solid Tumors With HRAS Alterations (1)

NCT	Acronym	Phase	Status	Title
NCT06026410	FIT-001	P1	recruiting	KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Metastatic Castration-resistant Prostate Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05613894	CaboLu	P1	suspended	Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Advanced Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05663710	—	P1/P2	recruiting	Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Locally Advanced Osteosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT05019703	—	P2	recruiting	Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Metastatic Papillary Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05411081	—	P2	active not recruiting	Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

High Grade Osteosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT05691478	—	P2/P3	recruiting	A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Castration-resistant Prostate Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05502315	CANOPY	P2	active not recruiting	Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

Metastatic Squamous Non-Small Cell Lung Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05613413	LUNG-IST-127	P2	recruiting	A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)

BCLC Stage B Hepatocellular Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05327738	—	P2	withdrawn	Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Clinical Stage III Cutaneous Melanoma AJCC v8 (1)

NCT	Acronym	Phase	Status	Title
NCT05136196	—	P2	recruiting	BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Recurrent Glioblastoma (1)

NCT	Acronym	Phase	Status	Title
NCT05039281	—	P1/P2	active not recruiting	Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Brain Metastases (1)

NCT	Acronym	Phase	Status	Title
NCT05048212	—	P2	recruiting	A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

Anal Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT05111574	—	P2	active not recruiting	Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Neuroblastoma (1)

NCT	Acronym	Phase	Status	Title
NCT05135975	—	P2	recruiting	A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Cancer of Kidney (1)

NCT	Acronym	Phase	Status	Title
NCT05241561	Cabo-POLARIS	P2	not yet recruiting	Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients

Refractory Cutaneous Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT05200143	—	P2	terminated	Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Advanced Bladder Urothelial Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05092958	—	P3	active not recruiting	Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Meningioma (1)

NCT	Acronym	Phase	Status	Title
NCT05425004	—	P2	recruiting	Cabozantinib for Patients With Recurrent or Progressive Meningioma

Advanced Breast Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05092373	TTF	P1	recruiting	Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Soft Tissue Sarcoma Adult (1)

NCT	Acronym	Phase	Status	Title
NCT05182164	PEMBROCABOSARC	P2	recruiting	Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas

Castration-Resistant Prostate Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT05168618	AtezoCab	P2	recruiting	Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Carcinoma Prostate (1)

NCT	Acronym	Phase	Status	Title
NCT05265988	MERIDIAN	P2	completed	Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib

Advanced Differentiated Thyroid Gland Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04514484	—	P1	active not recruiting	Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Hepatocellular Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05100082	—	N/A	completed	Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Neuroendocrine Tumors,Gastroenteropancreatic (1)

NCT	Acronym	Phase	Status	Title
NCT05048901	—	P1/P2	recruiting	Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Advanced Adult Hepatocellular Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04497038	—	P1/P2	terminated	Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation (1)

NCT	Acronym	Phase	Status	Title
NCT04878029	—	P1	recruiting	Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Esophageal Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT05007613	—	P2	completed	Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Colorectal Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04963283	MSS	P2	active not recruiting	Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Lung Neuroendocrine Neoplasm (1)

NCT	Acronym	Phase	Status	Title
NCT04893785	CABOTEM	P2	recruiting	A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)

Germ Cell Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT04876456	—	P2	active not recruiting	A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Locally Advanced Thyroid Gland Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06482086	—	P2	recruiting	Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Carcinoma, Non-small Cell Lung Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04151563	CheckMate 79X	P1/P2	withdrawn	A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

Carcinosarcoma of Ovary (1)

NCT	Acronym	Phase	Status	Title
NCT04149275	—	P2	withdrawn	Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Metastatic Hormone Refractory Prostate Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04477512	—	P1	completed	Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Metastatic Soft-tissue Sarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT04551430	—	P2	active not recruiting	Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Relapsed Ewing Sarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT04661852	—	P1	completed	Cabozantinib With Topotecan-Cyclophosphamide

High Grade Neuroendocrine Neoplasms (1)

NCT	Acronym	Phase	Status	Title
NCT04412629	—	P2	active not recruiting	Cabozantinib in High Grade Neuroendocrine Neoplasms

Papillary Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04413123	—	P2	active not recruiting	Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

Skin Angiosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT04339738	—	P2	active not recruiting	Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

HCC (1)

NCT	Acronym	Phase	Status	Title
NCT04588051	—	P2	active not recruiting	Cabozantinib in Hepatocellular Carcinoma

Metastatic Prostate Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04446117	CONTACT-02	P3	active not recruiting	Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Neuroendocrine Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT04400474	CABATEN	P2	completed	Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

Carcinoma, Non-Small-Cell Lung (1)

NCT	Acronym	Phase	Status	Title
NCT04471428	CONTACT-01	P3	completed	Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Metastatic Large Cell Neuroendocrine Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04079712	—	P2	active not recruiting	Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

Metastatic Well Differentiated Neuroendocrine Neoplasm (1)

NCT	Acronym	Phase	Status	Title
NCT04427787	LOLA	P2	unknown	A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

Sarcoma of the Extremity (1)

NCT	Acronym	Phase	Status	Title
NCT04220229	—	P1/P2	terminated	Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

Bladder Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04289779	ABATE	P2	active not recruiting	Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer

Cervical Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04230954	—	P2	terminated	Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (1)

NCT	Acronym	Phase	Status	Title
NCT03878524	SMMART	P1	terminated	Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT04091750	—	P2	active not recruiting	Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

Old Age; Debility (1)

NCT	Acronym	Phase	Status	Title
NCT04134390	CABOMAYOR	P2	completed	Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study

Gastric Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04164979	—	P2	active not recruiting	Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

Hepatocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT04435977	Immunocabo	P2	unknown	Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

Malignant Solid Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT04116541	MegaMOST	P2	recruiting	A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Advanced/Metastatic Cervical Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT04205799	CABOCOL-01	P2	completed	Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure

Metastatic Leiomyosarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT04200443	—	P2	active not recruiting	Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Urothelial Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03425201	NICARAGUA	P1/P2	completed	Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)

Bladder Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03824691	ARCADIA	P2	unknown	hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"

Refractory Colorectal Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT06171854	ABACO	P2	unknown	caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.

Advanced Metastatic Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT03957551	—	P1/P2	terminated	Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma

Penile Squamous Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03943602	CaboPen	P2	unknown	Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)

Autoimmune Disease (1)

NCT	Acronym	Phase	Status	Title
NCT03816345	—	P1	recruiting	Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Adrenocortical Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03612232	CaboACC	P2	unknown	Cabozantinib in Advanced Adrenocortical Carcinoma

Bladder Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03866382	—	P2	recruiting	Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Renal Cell Carcinoma Metastatic (1)

NCT	Acronym	Phase	Status	Title
NCT06377722	—	P2	terminated	Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Functioning Pancreatic Neuroendocrine Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT03375320	—	P3	active not recruiting	Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Gastric Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03539822	CAMILLA	P1/P2	recruiting	Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Metastatic Head and Neck Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03468218	—	P2	active not recruiting	Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Metastatic Urothelial Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03534804	PemCab	P2	completed	Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma

Head and Neck Squamous Cell Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03667482	—	P1	completed	Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Salivary Gland Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03729297	Cabo ASAP	P2	terminated	Cabozantinib in Advanced Salivary Gland Cancer Patients

Solid Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT03611595	—	P1	completed	Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03635892	—	P2	active not recruiting	A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Thyroid Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT03630120	TKI	P2	terminated	Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Malignant Neoplasms of Urinary Tract (1)

NCT	Acronym	Phase	Status	Title
NCT03541902	—	P2	active not recruiting	Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Advanced Endometrial Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT03367741	—	P2	active not recruiting	Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Metastatic Carcinoma in the Adrenal Cortex (1)

NCT	Acronym	Phase	Status	Title
NCT03370718	—	P2	completed	Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Collecting Duct Carcinoma (Kidney) (1)

NCT	Acronym	Phase	Status	Title
NCT03354884	BONSAI	P2	completed	caBozantinib in cOllectiNg ductS Renal Cell cArcInoma

Pancreatic Adenocarcinoma Metastatic (1)

NCT	Acronym	Phase	Status	Title
NCT03213626	—	P2	terminated	Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma

Glioblastoma Multiforme (1)

NCT	Acronym	Phase	Status	Title
NCT02885324	—	P2	terminated	Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Adrenal Cortical Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02867592	—	P2	active not recruiting	Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Metastatic Gastrointestinal Stromal Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT02216578	—	P2	completed	Ph II CABOGIST in GIST

Rare Tumor (1)

NCT	Acronym	Phase	Status	Title
NCT03239015	—	P2	unknown	Efficacy and Safety of Precision Therapy in Refractory Tumor

Non-small Cell Lung Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02795156	—	P2	completed	Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Locally Advanced Papillary Renal Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02761057	—	P2	completed	Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Non Small Cell Lung Cancer (NSCLC) (1)

NCT	Acronym	Phase	Status	Title
NCT02132598	XL184	P2	terminated	Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

Bladder Small Cell Neuroendocrine Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02496208	—	P1	active not recruiting	Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Fallopian Tube Clear Cell Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02315430	—	P2	completed	Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Locally Advanced Paraganglioma (1)

NCT	Acronym	Phase	Status	Title
NCT02302833	—	P2	completed	Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery

Uterine Sarcoma (1)

NCT	Acronym	Phase	Status	Title
NCT01979393	—	P2	completed	IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

ccRCC (1)

NCT	Acronym	Phase	Status	Title
NCT02293980	MK-3795-001	P1	active not recruiting	A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

NF1 (1)

NCT	Acronym	Phase	Status	Title
NCT02101736	NF105-CABO	P2	completed	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

Merkel Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT02036476	—	P2	terminated	Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Differentiated Thyroid Cancer (DTC) (1)

NCT	Acronym	Phase	Status	Title
NCT02041260	RAI	P2	unknown	A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

Relapsed Acute Myeloid Leukemia (1)

NCT	Acronym	Phase	Status	Title
NCT01961765	—	P1	completed	Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Bile Duct Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT01954745	XL-184	P2	completed	Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Recurrent Uveal Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT01835145	—	P2	completed	Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Recurrent Melanoma (1)

NCT	Acronym	Phase	Status	Title
NCT01835184	—	P1	terminated	Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Relapsed or Refractory Multiple Myeloma (1)

NCT	Acronym	Phase	Status	Title
NCT01866293	XL184	P1/P2	completed	Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Recurrent Non-Small Cell Lung Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01866410	—	P2	completed	Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

Poorly Differentiated Thyroid Gland Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01811212	—	P2	completed	Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

Endometrial Adenosquamous Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01935934	—	P2	completed	Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Recurrent Lung Non-Small Cell Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01708954	—	P2	active not recruiting	Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Refractory Soft Tissue Sarcomas (1)

NCT	Acronym	Phase	Status	Title
NCT01755195	—	P2	completed	Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Recurrent Malignant Solid Neoplasm (1)

NCT	Acronym	Phase	Status	Title
NCT01709435	—	P1	completed	Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Recurrent Fallopian Tube Carcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01716715	—	P2	completed	Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Prostatic Neoplasms (1)

NCT	Acronym	Phase	Status	Title
NCT01683994	—	P1/P2	completed	Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer

Bone Metastases (1)

NCT	Acronym	Phase	Status	Title
NCT01599793	—	P2	completed	Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Prostate Cancer Metastatic (1)

NCT	Acronym	Phase	Status	Title
NCT01428219	XL184	P2	terminated	Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Prostate Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT01347788	XL184	P1	completed	Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer

Astrocytic Tumors (1)

NCT	Acronym	Phase	Status	Title
NCT01068782	—	P2	terminated	Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Cabozantinib pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
EXAMINER	NCT01896479	P4	active not recruiting	Medullary Thyroid Cancer	247	PMID 35403447
CANIQOL	NCT07028125	P4	recruiting	Renal Cell Carcinoma (Kidney Cancer)	83	—
CABOLD	NCT06934057	P4	recruiting	Kidney Cancer	50	—
CLERANCE	NCT03963206	P4	completed	Hepatocellular Carcinoma	110	—
AcceleRET-MTC	NCT04760288	P3	withdrawn	Medullary Thyroid Cancer	0	—
STROKER	NCT06726421	P3	recruiting	Renal Cell Carcinoma (Kidney Cancer)	252	—
CARE1	NCT06364631	P3	recruiting	Metastatic Kidney Cancer	1,250	—
LITESPARK-033	NCT07227402	P3	recruiting	Renal Cell Carcinoma	904	—
IMbrella B	NCT03768063	P3	active not recruiting	Cancer	1,000	—
LIBRETTO-531	NCT04211337	P3	active not recruiting	Medullary Thyroid Cancer	291	PMID 35969032
MK-6482	NCT04586231	P3	active not recruiting	Carcinoma, Renal Cell	747	PMID 36752726
COSMIC-313	NCT03937219	P3	active not recruiting	Renal Cell Carcinoma	855	PMID 34550754
CONTACT-02	NCT04446117	P3	active not recruiting	Metastatic Prostate Cancer	575	PMID 40523369
VEGFR	NCT03690388	P3	active not recruiting	Differentiated Thyroid Cancer	187	PMID 38062732
COSMIC-312	NCT03755791	P3	active not recruiting	Hepatocellular Carcinoma	837	PMID 38364832
CheckMate 9ER	NCT03141177	P3	active not recruiting	Renal Cell Carcinoma	701	PMID 41617395
CONTACT-03	NCT04338269	P3	terminated	Carcinoma, Renal Cell	522	PMID 37290461
CONTACT-01	NCT04471428	P3	completed	Carcinoma, Non-Small-Cell Lung	366	PMID 34409776
TKI	NCT03729245	P3	terminated	Renal Cell Carcinoma	623	PMID 38838287
METEOR	NCT01865747	P3	completed	Renal Cell Carcinoma	658	PMID 34364385
CELESTIAL	NCT01908426	P3	completed	Hepatocellular Carcinoma	707	PMID 33822328
COMET-1	NCT01605227	P3	completed	Prostate Cancer	1,028	PMID 29272162
COMET-2	NCT01522443	P3	terminated	Prostate Cancer	119	PMID 35779938
REGN2810	NCT06900595	P2	recruiting	Locally Advanced Adrenal Cortical Carcinoma	48	—
RCC	NCT05931393	P2	recruiting	RCC	18	—
LUNG-IST-127	NCT05613413	P2	recruiting	Metastatic Squamous Non-Small Cell Lung Carcinoma	36	—
SKIPPY 2	NCT07077161	P2	recruiting	Renal Cell Carcinoma (RCC)	34	PMID 38874883
CAPIO	NCT07151326	P2	not yet recruiting	Hepatocellular Carcinoma (HCC)	60	—
Cabatezo-1	NCT05859217	P2	not yet recruiting	Lung Cancer	40	—
SAMURAI	NCT05327686	P2	recruiting	Metastatic Renal Cell Carcinoma	240	—
Cyto-KIK	NCT04322955	P2	active not recruiting	Kidney Cancer	38	—
PEMBROCABOSARC	NCT05182164	P2	recruiting	Soft Tissue Sarcoma Adult	119	—
DRUP	NCT02925234	P2	recruiting	Cancer	1,550	PMID 37424386
MegaMOST	NCT04116541	P2	recruiting	Malignant Solid Tumor	455	—
CANOPY	NCT05502315	P2	active not recruiting	Castration-resistant Prostate Cancer	47	—
Cabo-POLARIS	NCT05241561	P2	not yet recruiting	Cancer of Kidney	24	—
MK-6482-003	NCT03634540	P2	active not recruiting	Renal Cell Carcinoma (RCC)	118	PMID 37011650
MSS	NCT04963283	P2	active not recruiting	Colorectal Adenocarcinoma	48	—
AtezoCab	NCT05168618	P2	recruiting	Castration-Resistant Prostate Carcinoma	33	—
CPAB	NCT06535737	P2	not yet recruiting	Hepatocellular Carcinoma Non-resectable	40	PMID 21613405
CABOTEM	NCT04893785	P2	recruiting	Lung Neuroendocrine Neoplasm	35	PMID 41963331
CabOSTar	NCT06341712	P2	terminated	Osteosarcoma	10	—
CaboPoint	NCT03945773	P2	completed	Locally Advanced or Metastatic Renal Cell Carcinoma	127	PMID 34911359
ABATE	NCT04289779	P2	active not recruiting	Bladder Cancer	46	—
NEN G3	NCT05289856	P2	unknown	Cancer	30	—
CABOTHYROID	NCT05660954	P2	completed	Differentiated Thyroid Cancer	41	—
UNICAB	NCT03685448	P2	completed	Renal Cell Carcinoma	35	—
CaboACC	NCT03612232	P2	unknown	Adrenocortical Carcinoma	37	PMID 26282167
HCC	NCT04511455	P2	completed	Hepatocellular Carcinoma Non-resectable	22	—
ABACO	NCT06171854	P2	unknown	Refractory Colorectal Adenocarcinoma	33	—
CABRAMET	NCT03967522	P2	completed	Metastatic Renal Cell Carcinoma	26	PMID 41946178
CABONEN	NCT04524208	P2	active not recruiting	Neuroendocrine Tumors	45	—
CaPture	NCT04767906	P2	completed	Hepatocellular Carcinoma	16	—
MERIDIAN	NCT05265988	P2	completed	Carcinoma Prostate	32	PMID 28396734
PemCab	NCT03534804	P2	completed	Metastatic Urothelial Carcinoma	37	—
CaboCHILD	NCT04454762	P2	unknown	Hepatocellular Carcinoma	20	—
CABATEN	NCT04400474	P2	completed	Neuroendocrine Tumor	93	—
LOLA	NCT04427787	P2	unknown	Metastatic Well Differentiated Neuroendocrine Neoplasm	69	PMID 16801334
CABOMAYOR	NCT04134390	P2	completed	Old Age; Debility	25	—
Immunocabo	NCT04435977	P2	unknown	Hepatocarcinoma	46	—
TKI	NCT05039736	P2	withdrawn	Hepatocellular Carcinoma	0	—
ARCADIA	NCT03824691	P2	unknown	Bladder Carcinoma	122	PMID 28481359
ACTION	NCT04316182	P2	completed	Hepatocellular Carcinoma	24	—
CABOCOL-01	NCT04205799	P2	completed	Advanced/Metastatic Cervical Cancer	57	PMID 34563169
CaboPen	NCT03943602	P2	unknown	Penile Squamous Cell Carcinoma	37	PMID 20980789
CRETA	NCT04131543	P2	unknown	Non Small Cell Lung Cancer	25	PMID 17167516
RAI	NCT02041260	P2	unknown	Differentiated Thyroid Cancer (DTC)	43	—
NF105-CABO	NCT02101736	P2	completed	NF1	45	PMID 33442015
CANTATA	NCT03428217	P2	completed	Advanced Renal Cell Carcinoma	444	PMID 36048457
CabUC	NCT04066595	P2	terminated	Urothelial Carcinoma	7	—
SPARC	NCT03964337	P2	terminated	Prostate Cancer	3	—
BONSAI	NCT03354884	P2	completed	Collecting Duct Carcinoma (Kidney)	23	PMID 35420628
CABinMET	NCT03911193	P2	unknown	Non-Small Cell Lung Cancer	25	—
TKI	NCT03630120	P2	terminated	Thyroid Cancer	6	—
Cabo ASAP	NCT03729297	P2	terminated	Salivary Gland Cancer	25	PMID 37939426
XL184	NCT02132598	P2	terminated	Non Small Cell Lung Cancer (NSCLC)	5	—
XL184	NCT01834651	P2	completed	Prostate Cancer	17	—
XL-184	NCT01954745	P2	completed	Bile Duct Cancer	19	PMID 28192597
XL184	NCT01428219	P2	terminated	Prostate Cancer Metastatic	25	—
XL184	NCT00940225	P2	completed	Solid Tumors	730	PMID 27714541

Terminated and withdrawn Cabozantinib trials (37)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

NCT04760288withdrawnA Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).
NCT05613894suspendedDose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT05904080suspendedTesting Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
NCT05327738withdrawnYttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma
NCT04151563withdrawnA Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy
NCT06341712terminatedEffects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
NCT06716853terminatedA Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma
NCT04631744terminatedCabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
NCT03957551terminatedCabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
NCT04338269terminatedA Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
NCT04220229terminatedCabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities
NCT05200143terminatedStudy of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
NCT04300140terminatedSafety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
NCT05039736withdrawnA Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
NCT04497038terminatedCabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
NCT03729245terminatedA Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
NCT06377722terminatedCabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
NCT04173338terminatedCabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
NCT04442581terminatedCabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
NCT04230954terminatedCabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
NCT04066595terminatedCabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.
NCT03964337terminatedImmediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer
NCT03201250terminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
NCT04149275withdrawnCabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma
NCT03878524terminatedSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
NCT02885324terminatedPilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
NCT03630120terminatedAdaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
NCT03213626terminatedCabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma
NCT03729297terminatedCabozantinib in Advanced Salivary Gland Cancer Patients
NCT02132598terminatedTrial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
NCT02036476terminatedCabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
NCT01428219terminatedTrial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone
NCT01703065terminatedCabozantinib in Men With Castration-Resistant Prostate Cancer
NCT01522443terminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
NCT01995058terminatedCombo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
NCT01068782terminatedMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
NCT01835184terminatedCabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

All Cabozantinib trials (251)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT04760288	AcceleRET-MTC	A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).	P3	withdrawn	0	Hoffmann-La Roche	Nov 2023
NCT01896479	EXAMINER	A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer	P4	active not recruiting	247	Exelixis	Feb 2015
NCT06502171	NF113	Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas	P1	not yet recruiting	30	Girish Dhall, MD	Aug 2026
NCT07383441		Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer	P3	recruiting	718	SWOG Cancer Research Network	Jun 2026
NCT07405164		Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)	P3	recruiting	450	Merck Sharp & Dohme LLC	Mar 2026
NCT06726421	STROKER	Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)	P3	recruiting	252	Sun Yat-sen University	Sep 2024
NCT06364631	CARE1	CARE1 Pragmatic Clinical Trial	P3	recruiting	1,250	Gustave Roussy, Cancer Campus, Grand Paris	Apr 2024
NCT07227402	LITESPARK-033	A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)	P3	recruiting	904	Merck Sharp & Dohme LLC	Nov 2025
NCT07293351	RCC	A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)	P1/P2	recruiting	254	Bristol-Myers Squibb	Mar 2026
NCT07011719		Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma	P3	recruiting	720	Arcus Biosciences, Inc.	Sep 2025
NCT07194044	METTSEO	Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes	P1	recruiting	15	H. Lee Moffitt Cancer Center and Research Institute	Feb 2026
NCT06475989		Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer	P3	recruiting	264	ECOG-ACRIN Cancer Research Group	Aug 2024
NCT05691478		A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	P2/P3	recruiting	1,122	National Cancer Institute (NCI)	Mar 2023
NCT05249114		Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors	P1	active not recruiting	6	Providence Health & Services	Dec 2022
NCT05135975		A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors	P2	recruiting	86	Nationwide Children's Hospital	Jul 2022
NCT03899155		Pan Tumor Rollover Study	P2	recruiting	1,500	Bristol-Myers Squibb	Aug 2019
NCT05092958		Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study	P3	active not recruiting	654	National Cancer Institute (NCI)	Jun 2022
NCT03539822	CAMILLA	Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies	P1/P2	recruiting	117	Anwaar Saeed	Oct 2018
NCT06900595	REGN2810	Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer	P2	recruiting	48	National Cancer Institute (NCI)	Feb 2026
NCT05773274		Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial	P2	recruiting	100	National Cancer Institute (NCI)	Jan 2024
NCT07187869		Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study	P1	not yet recruiting	16	M.D. Anderson Cancer Center	Mar 2026
NCT05536141	ARC-20	A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors	P1	recruiting	362	Arcus Biosciences, Inc.	Oct 2022
NCT04551430		Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma	P2	active not recruiting	105	Washington University School of Medicine	Jan 2021
NCT07028125	CANIQOL	Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma	P4	recruiting	83	Centre Francois Baclesse	Oct 2025
NCT07010393		Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study	P4	not yet recruiting	335	Fujian Medical University	Jul 2025
NCT05931393	RCC	Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)	P2	recruiting	18	University of Texas Southwestern Medical Center	Dec 2023
NCT05613894	CaboLu	Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer	P1	suspended	33	University of Utah	Jul 2023
NCT04588051		Cabozantinib in Hepatocellular Carcinoma	P2	active not recruiting	20	Stephen Chan Lam	Nov 2020
NCT04878029		Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer	P1	recruiting	32	Emory University	Jul 2021
NCT06006013		Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer	P2	recruiting	21	Emory University	Jan 2025
NCT06156410		Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas	P1	recruiting	30	Children's Hospital of Philadelphia	Oct 2023
NCT05613413	LUNG-IST-127	A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)	P2	recruiting	36	University of Illinois at Chicago	Dec 2022
NCT07077161	SKIPPY 2	Cabozantinib Dose Skipping as an Alternative to Dose Reductions	P2	recruiting	34	dr. Tom van der Hulle	Jan 2026
NCT03768063	IMbrella B	A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study	P3	active not recruiting	1,000	Hoffmann-La Roche	Feb 2019
NCT07151326	CAPIO	Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy	P2	not yet recruiting	60	National Health Research Institutes, Taiwan	Sep 2025
NCT05859217	Cabatezo-1	A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)	P2	not yet recruiting	40	Jun Zhang, MD, PhD	Dec 2024
NCT05904080		Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer	P2	suspended	50	National Cancer Institute (NCI)	Feb 2024
NCT05327686	SAMURAI	Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial	P2	recruiting	240	NRG Oncology	Feb 2023
NCT05425004		Cabozantinib for Patients With Recurrent or Progressive Meningioma	P2	recruiting	24	Baptist Health South Florida	Jun 2022
NCT06934057	CABOLD	Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma	P4	recruiting	50	Gustave Roussy, Cancer Campus, Grand Paris	May 2025
NCT03816345		Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO	P1	recruiting	300	National Cancer Institute (NCI)	Jul 2019
NCT04322955	Cyto-KIK	CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition	P2	active not recruiting	38	Mark Stein	Jun 2020
NCT03793166		Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study	P3	active not recruiting	1,175	National Cancer Institute (NCI)	Jun 2019
NCT05127824		Autologous Dendritic Cell Vaccine in Kidney Cancer	P2	recruiting	42	Jodi Maranchie	Jul 2023
NCT05019703		Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study	P2	recruiting	40	M.D. Anderson Cancer Center	Apr 2023
NCT05039281		Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma	P1/P2	active not recruiting	47	M.D. Anderson Cancer Center	Sep 2022
NCT05048212		A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases	P2	recruiting	20	M.D. Anderson Cancer Center	Sep 2022
NCT05182164	PEMBROCABOSARC	Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas	P2	recruiting	119	Institut Bergonié	Apr 2022
NCT05048901		Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors	P1/P2	recruiting	49	National Health Research Institutes, Taiwan	Sep 2021
NCT02925234	DRUP	The Drug Rediscovery Protocol (DRUP Trial)	P2	recruiting	1,550	The Netherlands Cancer Institute	Aug 2016
NCT05327738		Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma	P2	withdrawn	0	OHSU Knight Cancer Institute	Dec 2022
NCT06132945		A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain	P1	active not recruiting	2	Memorial Sloan Kettering Cancer Center	Nov 2023
NCT04211337	LIBRETTO-531	A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer	P3	active not recruiting	291	Loxo Oncology, Inc.	Feb 2020
NCT04116541	MegaMOST	A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.	P2	recruiting	455	Centre Leon Berard	Jan 2020
NCT05663710		Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC	P1/P2	recruiting	100	M.D. Anderson Cancer Center	Jun 2023
NCT05012371		Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer	P2	active not recruiting	90	M.D. Anderson Cancer Center	Feb 2022
NCT03170960		Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors	P1	active not recruiting	914	Exelixis	Sep 2017
NCT04472767		Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma	P2	recruiting	35	University of California, Irvine	Aug 2020
NCT06811116		Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial	P1/P2	recruiting	92	National Cancer Institute (NCI)	Nov 2025
NCT03541902		Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma	P2	active not recruiting	32	M.D. Anderson Cancer Center	May 2018
NCT05502315	CANOPY	Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer	P2	active not recruiting	47	Rana McKay, MD	Feb 2023
NCT05411081		Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial	P2	active not recruiting	200	National Cancer Institute (NCI)	Mar 2023
NCT05361720		Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study	P2	recruiting	54	Vanderbilt-Ingram Cancer Center	Dec 2022
NCT06026410	FIT-001	KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors	P1	recruiting	300	Kura Oncology, Inc.	Oct 2023
NCT05241561	Cabo-POLARIS	Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients	P2	not yet recruiting	24	Centre Hospitalier Universitaire de Besancon	Jun 2022
NCT04412629		Cabozantinib in High Grade Neuroendocrine Neoplasms	P2	active not recruiting	35	Washington University School of Medicine	Nov 2020
NCT01708954		Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer	P2	active not recruiting	125	National Cancer Institute (NCI)	Feb 2013
NCT06835972		A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)	P1/P2	recruiting	43	Memorial Sloan Kettering Cancer Center	Feb 2025
NCT05263050		Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors	P2	recruiting	111	Fox Chase Cancer Center	Jan 2022
NCT03866382		Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	P2	recruiting	314	National Cancer Institute (NCI)	May 2019
NCT03634540	MK-6482-003	A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)	P2	active not recruiting	118	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Sep 2018
NCT04586231	MK-6482	A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)	P3	active not recruiting	747	Merck Sharp & Dohme LLC	Feb 2021
NCT04963283	MSS	Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer	P2	active not recruiting	48	University of Colorado, Denver	Jun 2021
NCT04514484		Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV	P1	active not recruiting	8	National Cancer Institute (NCI)	Nov 2021
NCT05168618	AtezoCab	Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer	P2	recruiting	33	University of Utah	Mar 2022
NCT04820179		Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer	P2	active not recruiting	30	University of Arizona	Oct 2021
NCT04876456		A Phase II Trial of Cabozantinib With Patients With Refractory GCTs	P2	active not recruiting	50	Jennifer King	Jun 2021
NCT03937219	COSMIC-313	Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma	P3	active not recruiting	855	Exelixis	Jun 2019
NCT04339738		Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma	P2	active not recruiting	90	National Cancer Institute (NCI)	Nov 2020
NCT05122546		CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer	P1	active not recruiting	31	City of Hope Medical Center	Nov 2021
NCT05136196		BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study	P2	recruiting	150	National Cancer Institute (NCI)	Dec 2022
NCT06535737	CPAB	A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab	P2	not yet recruiting	40	Chulalongkorn University	Aug 2024
NCT05188118		Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma	Early P1	recruiting	20	Icahn School of Medicine at Mount Sinai	Feb 2023
NCT05168163		Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	P2	recruiting	122	Academic and Community Cancer Research United	May 2022
NCT04893785	CABOTEM	A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)	P2	recruiting	35	National Cancer Institute, Naples	Jun 2021
NCT04310007		Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer	P2	active not recruiting	117	National Cancer Institute (NCI)	Jul 2020
NCT04091750		Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma	P2	active not recruiting	14	Georgetown University	Mar 2020
NCT04413123		Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC	P2	active not recruiting	60	Bradley A. McGregor, MD	Nov 2020
NCT03914300		Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer	P2	active not recruiting	11	National Cancer Institute (NCI)	Feb 2020
NCT04022343		Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer	P2	active not recruiting	22	Emory University	Aug 2019
NCT02293980	MK-3795-001	A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)	P1	active not recruiting	110	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Nov 2014
NCT03468218		Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer	P2	active not recruiting	36	Emory University	Sep 2018
NCT04446117	CONTACT-02	Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC	P3	active not recruiting	575	Exelixis	Oct 2020
NCT04071223		Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study	P2	active not recruiting	134	National Cancer Institute (NCI)	Jul 2020
NCT02496208		Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	P1	active not recruiting	152	National Cancer Institute (NCI)	Jul 2015
NCT04200443		Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma	P2	active not recruiting	96	City of Hope Medical Center	Jan 2020
NCT05111574		Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery	P2	active not recruiting	101	National Cancer Institute (NCI)	Aug 2022
NCT05092373	TTF	Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax	P1	recruiting	43	M.D. Anderson Cancer Center	Apr 2022
NCT03635892		A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma	P2	active not recruiting	60	Memorial Sloan Kettering Cancer Center	Aug 2018
NCT04079712		Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors	P2	active not recruiting	17	National Cancer Institute (NCI)	Aug 2020
NCT03375320		Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	P3	active not recruiting	298	National Cancer Institute (NCI)	Oct 2018
NCT03690388	VEGFR	A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy	P3	active not recruiting	187	Exelixis	Oct 2018
NCT03755791	COSMIC-312	Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy	P3	active not recruiting	837	Exelixis	Jun 2018
NCT01639508		Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity	P2	recruiting	86	Memorial Sloan Kettering Cancer Center	Jul 2012
NCT03367741		Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer	P2	active not recruiting	82	National Cancer Institute (NCI)	Apr 2018
NCT02243605		Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma	P2	active not recruiting	90	National Cancer Institute (NCI)	Dec 2014
NCT05797805	BC2059	A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma	P1/P2	recruiting	178	Iterion Therapeutics	Sep 2023
NCT04204850		Cabozantinib to Treat Recurrent Liver Cancer Post Transplant	P2	recruiting	20	University Health Network, Toronto	Aug 2020
NCT02867592		Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors	P2	active not recruiting	109	National Cancer Institute (NCI)	May 2017
NCT04164979		Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma	P2	active not recruiting	34	University of California, Irvine	Feb 2020
NCT05836571		Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma	P2	active not recruiting	66	National Cancer Institute LAO	Oct 2023
NCT04151563	CheckMate 79X	A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy	P1/P2	withdrawn	0	Bristol-Myers Squibb	Apr 2021
NCT05038839		Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors	P1	completed	44	M.D. Anderson Cancer Center	Feb 2022
NCT03611595		Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors	P1	completed	15	Peter Zage	Aug 2018
NCT06341712	CabOSTar	Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma	P2	terminated	10	Ipsen	Nov 2024
NCT03945773	CaboPoint	Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors	P2	completed	127	Ipsen	Jan 2020
NCT06716853	TEM-GU	A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma	P1/P2	terminated	10	Genenta Science	Oct 2024
NCT03141177	CheckMate 9ER	A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma	P3	active not recruiting	701	Bristol-Myers Squibb	Jul 2017
NCT04289779	ABATE	Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer	P2	active not recruiting	46	Deepak Kilari	May 2020
NCT03899428		Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC	P2	recruiting	30	Humanity & Health Medical Group Limited	May 2019
NCT05289856	NEN G3	Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)	P2	unknown	30	Johannes Gutenberg University Mainz	Mar 2022
NCT06482086		Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer	P2	recruiting	75	West China Hospital	Jun 2021
NCT05660954	CABOTHYROID	Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.	P2	completed	41	Grupo Espanol de Tumores Neuroendocrinos	May 2023
NCT05100082		Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma	—	completed	263	Takeda	Nov 2021
NCT04631744		Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)	P2	terminated	4	Weill Medical College of Cornell University	Mar 2021
NCT03957551		Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma	P1/P2	terminated	28	John Rieth	Aug 2019
NCT04477512		Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)	P1	completed	18	Washington University School of Medicine	Feb 2021
NCT06548867	CABOGEN	Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib	—	recruiting	80	Gruppo Oncologico Italiano di Ricerca Clinica	May 2024
NCT03685448	UNICAB	ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)	P2	completed	35	Australian and New Zealand Urogenital and Prostate Cancer Trials Group	Apr 2019
NCT03612232	CaboACC	Cabozantinib in Advanced Adrenocortical Carcinoma	P2	unknown	37	Wuerzburg University Hospital	Jun 2019
NCT04338269	CONTACT-03	A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment	P3	terminated	522	Hoffmann-La Roche	Jul 2020
NCT03798626		Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers	P1	completed	167	Novartis Pharmaceuticals	May 2019
NCT04471428	CONTACT-01	Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy	P3	completed	366	Hoffmann-La Roche	Oct 2020
NCT04511455	HCC	Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment	P2	completed	22	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Dec 2020
NCT06171854	ABACO	caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer.	P2	unknown	33	University of Campania Luigi Vanvitelli	Sep 2019
NCT05007613		Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma	P2	completed	24	National Taiwan University Hospital	Jun 2021
NCT02302833		Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery	P2	completed	21	M.D. Anderson Cancer Center	Feb 2015
NCT01658878	CheckMate040	An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer	P1/P2	completed	657	Bristol-Myers Squibb	Oct 2012
NCT05052723		Cabozantinib and Pembrolizumab in Metastatic Pancreas	P2	completed	21	Joseph Kim	Jan 2022
NCT03967522	CABRAMET	Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases	P2	completed	26	Centre Leon Berard	Nov 2019
NCT04524208	CABONEN	A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3	P2	active not recruiting	45	Karsten Gavenis	Mar 2021
NCT04220229		Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities	P1/P2	terminated	6	University of Washington	Jun 2020
NCT01935934		Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	P2	completed	102	National Cancer Institute (NCI)	May 2013
NCT04522908		Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function	P2	completed	40	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	Oct 2020
NCT03425201	NICARAGUA	Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)	P1/P2	completed	67	Fundacion CRIS de Investigación para Vencer el Cáncer	Oct 2019
NCT04804813		Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma	—	completed	388	Takeda	Mar 2021
NCT05200143		Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma	P2	terminated	4	Providence Health & Services	Jun 2022
NCT04767906	CaPture	Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors	P2	completed	16	University of Leipzig	Dec 2021
NCT03667482		Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer	P1	completed	20	Memorial Sloan Kettering Cancer Center	Sep 2018
NCT05265988	MERIDIAN	Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib	P2	completed	32	Alfredo Berruti	Nov 2021
NCT03534804	PemCab	Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma	P2	completed	37	University of Utah	Sep 2018
NCT04868773		Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy	P1	completed	15	University of California, Irvine	Jul 2021
NCT02592356		Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer	N/A	completed	23	M.D. Anderson Cancer Center	Nov 2015
NCT03149822		Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma	P1/P2	completed	45	University of Colorado, Denver	Sep 2017
NCT04454762	CaboCHILD	A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function	P2	unknown	20	Johannes Gutenberg University Mainz	Jul 2020
NCT04197310		Cabozantinib and Nivolumab for Carcinoid Tumors	P2	completed	19	Dana-Farber Cancer Institute	Dec 2019
NCT04540705	PIVOT IO 011	A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread	P1	completed	30	Bristol-Myers Squibb	Sep 2020
NCT01979393		IRCI Gynae Sarcomas, High Grade Uterine Sarcoma	P2	completed	58	European Organisation for Research and Treatment of Cancer - EORTC	Feb 2015
NCT03370718		Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma	P2	completed	18	M.D. Anderson Cancer Center	Feb 2018
NCT04416646	ZEBRA	Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma	—	completed	100	Istituto Oncologico Veneto IRCCS	Feb 2019
NCT03239015		Efficacy and Safety of Precision Therapy in Refractory Tumor	P2	unknown	300	Baodong Qin	Jan 2017
NCT01466036		Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	P2	completed	61	Dana-Farber Cancer Institute	Jul 2012
NCT04400474	CABATEN	Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study	P2	completed	93	Grupo Espanol de Tumores Neuroendocrinos	Oct 2020
NCT04427787	LOLA	A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET	P2	unknown	69	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Jun 2020
NCT04134390	CABOMAYOR	Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study	P2	completed	25	Spanish Oncology Genito-Urinary Group	Feb 2020
NCT02761057		Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed	P2	completed	152	National Cancer Institute (NCI)	Jul 2016
NCT04435977	Immunocabo	Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma	P2	unknown	46	Istituto Clinico Humanitas	Jan 2020
NCT01755195		Cabozantinib for Adults With Advanced Soft Tissue Sarcoma	P2	completed	55	National Cancer Institute (NCI)	Jan 2013
NCT04300140		Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma	P1/P2	terminated	72	Aravive, Inc.	Feb 2021
NCT05039736	TKI	A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy	P2	withdrawn	0	M.D. Anderson Cancer Center	Feb 2023
NCT04497038		Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy	P1/P2	terminated	3	University of Michigan Rogel Cancer Center	Aug 2021
NCT03824691	ARCADIA	hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"	P2	unknown	122	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Sep 2019
NCT04316182	ACTION	Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)	P2	completed	24	Fundacion Clinic per a la Recerca Biomédica	Jul 2020
NCT04205799	CABOCOL-01	Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure	P2	completed	57	Centre Francois Baclesse	Jan 2020
NCT03468985		Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer	P2	completed	3	National Cancer Institute (NCI)	May 2018
NCT04661852		Cabozantinib With Topotecan-Cyclophosphamide	P1	completed	12	Dana-Farber Cancer Institute	Dec 2020
NCT03729245	TKI	A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)	P3	terminated	623	Nektar Therapeutics	Dec 2018
NCT03943602	CaboPen	Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)	P2	unknown	37	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Aug 2019
NCT02795156		Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations	P2	completed	100	SCRI Development Innovations, LLC	Sep 2016
NCT06377722		Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer	P2	terminated	18	Fundacion Oncosur	Nov 2018
NCT04131543	CRETA	Phase II Study With Cabozantinib in Patients With RET Positive NSCLC	P2	unknown	25	University of Bologna	Aug 2019
NCT04510688	SRWEC	Spanish Real-World Evidence Cabozantinib	—	completed	275	Spanish Oncology Genito-Urinary Group	Oct 2019
NCT02041260	RAI	A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting	P2	unknown	43	Thomas Jefferson University	Jan 2014
NCT04173338		Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma	P1	terminated	9	Augusta University	Jan 2020
NCT04442581		Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer	P2	terminated	2	University of Washington	Apr 2021
NCT03542877		Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer	P2	completed	44	Academic Thoracic Oncology Medical Investigators Consortium	Jun 2018
NCT04230954		Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer	P2	terminated	5	University of South Alabama	Apr 2020
NCT02101736	NF105-CABO	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults	P2	completed	45	University of Alabama at Birmingham	Jun 2014
NCT03200587		Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)	P1	completed	12	University of Utah	Jun 2018
NCT03963206	CLERANCE	Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)	P4	completed	110	Hospices Civils de Lyon	Sep 2019
NCT03299946	HCC	Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)	P1	completed	15	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	May 2018
NCT03428217	CANTATA	CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma	P2	completed	444	Calithera Biosciences, Inc	Apr 2018
NCT04066595	CabUC	Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma.	P2	terminated	7	Johannes Gutenberg University Mainz	Feb 2020
NCT01574937		XL-184+Abiraterone in Post-Chemo CRPC	P1	completed	27	Dana-Farber Cancer Institute	Apr 2012
NCT03586973		A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma	P2	completed	34	Takeda	Aug 2018
NCT03964337	SPARC	Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer	P2	terminated	3	Duke University	Mar 2020
NCT01822522		Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus	P1	completed	36	National Cancer Institute (NCI)	Jun 2013
NCT03201250		Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma	P1/P2	terminated	11	University of Nebraska	Feb 2018
NCT01630590		Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer	P2	completed	62	M.D. Anderson Cancer Center	Jan 2014
NCT04149275		Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma	P2	withdrawn	0	University of Alabama at Birmingham	Feb 2021
NCT02216578		Ph II CABOGIST in GIST	P2	completed	51	European Organisation for Research and Treatment of Cancer - EORTC	Feb 2017
NCT01865747	METEOR	A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma	P3	completed	658	Exelixis	Jun 2013
NCT01908426	CELESTIAL	Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib	P3	completed	707	Exelixis	Sep 2013
NCT04637204		Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England	—	completed	1,540	Ipsen	Nov 2020
NCT03878524	SMMART	Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial	P1	terminated	2	OHSU Knight Cancer Institute	Apr 2020
NCT03354884	BONSAI	caBozantinib in cOllectiNg ductS Renal Cell cArcInoma	P2	completed	23	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Jan 2018
NCT03911193	CABinMET	CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation	P2	unknown	25	Fondazione Ricerca Traslazionale	Sep 2018
NCT01688999		Cabozantinib for Advanced Urothelial Cancer	P2	completed	69	National Cancer Institute (NCI)	Sep 2012
NCT03339219		A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma	P2	completed	35	Takeda	Dec 2017
NCT02885324		Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children	P2	terminated	4	Indiana University	May 2017
NCT04353765	US NIS Cabo	Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors	—	completed	247	Ipsen	Jan 2020
NCT02260531		Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases	P2	completed	36	Dana-Farber Cancer Institute	Nov 2014
NCT01709435		Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors	P1	completed	41	National Cancer Institute (NCI)	Nov 2012
NCT03630120	TKI	Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer	P2	terminated	6	H. Lee Moffitt Cancer Center and Research Institute	Aug 2018
NCT03213626		Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma	P2	terminated	7	Patrick Joseph Loehrer Sr.	Oct 2017
NCT03729297	Cabo ASAP	Cabozantinib in Advanced Salivary Gland Cancer Patients	P2	terminated	25	Radboud University Medical Center	Sep 2018
NCT01835145		Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery	P2	completed	47	National Cancer Institute (NCI)	Jul 2013
NCT03316586		A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer	P2	completed	18	Dana-Farber Cancer Institute	Nov 2017
NCT02132598	XL184	Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases	P2	terminated	5	Liza Villaruz, MD	Dec 2015
NCT01441947		Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer	P2	completed	68	Massachusetts General Hospital	Oct 2011
NCT01588821		Cabozantinib in Advanced Solid Malignancies	P2	completed	37	Massachusetts General Hospital	Jun 2012
NCT01812668		Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer	N/A	completed	20	Barbara Ann Karmanos Cancer Institute	Mar 2013
NCT02315430		Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	P2	completed	13	National Cancer Institute (NCI)	Apr 2015
NCT01716715		Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer	P2	completed	111	National Cancer Institute (NCI)	Nov 2012
NCT01683994		Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer	P1/P2	completed	49	National Cancer Institute (NCI)	Sep 2012
NCT01599793		Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer	P2	completed	19	University of Chicago	May 2012
NCT02008383	CaboMAb	Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer	P1	completed	29	John Strickler, M.D.	Jan 2014
NCT01866410		Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer	P2	completed	37	National Cancer Institute (NCI)	May 2013
NCT01811212		Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer	P2	completed	25	National Cancer Institute (NCI)	May 2013
NCT01663272	XL184	A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer	P1	completed	12	University of Michigan Rogel Cancer Center	Jul 2012
NCT01961765		Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia	P1	completed	18	Massachusetts General Hospital	Nov 2013
NCT01866293	XL184	Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma	P1/P2	completed	11	Memorial Sloan Kettering Cancer Center	May 2013
NCT02036476		Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma	P2	terminated	8	Dana-Farber Cancer Institute	Feb 2014
NCT01834651	XL184	A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases	P2	completed	17	Edwin Posadas, MD	Apr 2013
NCT01954745	XL-184	Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma	P2	completed	19	Massachusetts General Hospital	Sep 2013
NCT01428219	XL184	Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone	P2	terminated	25	University of Michigan Rogel Cancer Center	Feb 2012
NCT01703065		Cabozantinib in Men With Castration-Resistant Prostate Cancer	P2	terminated	9	University of Washington	Jun 2013
NCT01553656	XL184	Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer	P1	completed	85	Exelixis	Feb 2011
NCT01738438		Cabozantinib for Metastatic Triple Negative BrCa	P2	completed	35	Dana-Farber Cancer Institute	Feb 2013
NCT01605227	COMET-1	Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100	P3	completed	1,028	Exelixis	Jul 2012
NCT01522443	COMET-2	Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer	P3	terminated	119	Exelixis	Mar 2012
NCT01995058		Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC	P2	terminated	54	Exelixis	Feb 2014
NCT01582295	MM	XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease	P1	completed	4	Massachusetts General Hospital	Jun 2012
NCT01493869	XL184	Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects	P1	completed	26	Exelixis	Sep 2011
NCT01761773	XL184	A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function	P1	completed	32	Exelixis	Dec 2012
NCT00940225	XL184	Study of Cabozantinib (XL184) in Adults With Advanced Malignancies	P2	completed	730	Exelixis	Sep 2009
NCT01068782		Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse	P2	terminated	19	Exelixis	Apr 2010
NCT01835158		Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer	P2	completed	157	National Cancer Institute (NCI)	Jul 2013
NCT01835184		Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery	P1	terminated	5	National Cancer Institute (NCI)	May 2013
NCT01347788	XL184	Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer	P1	completed	34	Massachusetts General Hospital	Apr 2011
NCT01683110		Expanded Access of Cabozantinib in Medullary Thyroid Cancer	—	approved for marketing	0	Exelixis	—

Cabozantinib clinical trials: frequently asked questions

How many Cabozantinib clinical trials are there?: 251 Cabozantinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 54 are actively recruiting participants. 88 are marked completed.
Are Cabozantinib clinical trials recruiting in 2026?: Yes — 54 Cabozantinib trials are actively recruiting in 2026, with 1549 U.S. sites across 51 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Cabozantinib being studied for?: Cabozantinib is being studied for Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Hepatocellular Carcinoma, Stage IV Renal Cell Cancer AJCC v8, Clear Cell Renal Cell Carcinoma and 748 more. The trials are grouped by indication on this page.
What phase is Cabozantinib in?: Cabozantinib clinical trials span 5 Phase 4, 26 Phase 3, 147 Phase 2, 41 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Cabozantinib clinical trials?: The lead sponsor across the most Cabozantinib trials is National Cancer Institute (NCI), with 115 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Cabozantinibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed July 17, 2026.

Related pages on Hipa.ai:

Cabozantinib overview Cabozantinib evidence & publications